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ABSTRACT
In an effort to probe the structure and mechanism of metallo--lactamases, the
metal-binding behaviors of several enzymes were studied using EXAFS (Extended X-ray
Absorption Fine Structure). Three members of the metallo--lactamase subclass B1, BcII
from Bacillus cereus, Bla2 from Bacillus anthracis and CcrA from Bacillus fragilis, were
compared to examine metal-binding behavior within a subclass. Each system exhibits
different metal-binding behavior including cooperative binding (BcII), sequential binding
(CcrA), and differential binding between zinc(II) and cobalt(II) forms (Bla2). The metalbinding behavior of subclass B3 of L1 from Stenotrophomonas maltophilia was explored
with RFQ (rapid-freeze quenched) EXAFS and site selective metal substitution. RFQ
EXAFS show the metal coordination at 10 ms in the reaction in the native enzyme
including a zinc-zinc distance (3.72Å) greater than is present in either the resting or
product-bound states. Metal substitution incorporates cobalt(II) into the Zn2(DHH) of the
enzyme and showed the metal-binding at each metal site.
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Chapter I
Metallo--Lactamase Family

Introduction
The metallo--lactamase family is a class of enzymes with a unique 
sandwich fold. Among the members of this family are the three subclasses of metallo-lactamases, glyoxalase 2, and the quorum sensing lactonases. This family of enzymes has
a metal binding site at the interface between the two -sheet domains which binds most
divalent cations, but preferentially binds one or two equivalents of zinc in the case of
metallo--lactamases and lactonases, one iron and one zinc in the case of glyoxalase 2,
and two irons in the case of rubredoxin:oxygen oxidoreductase. The substrates of these
enzymes vary dramatically, but each catalyzes the hydrolysis at a carbonyl.

Metallo--Lactamases
Through the widespread use, abuse, and misuse of -lactam antibiotics selective
pressures on the bacterial population has led to the appearance of resistant strains. [1-4]
These resistant strains emerge within a few years of the drugs introduction and grow
more prevalent as the drug’s use becomes widespread. Despite the ongoing progress of
antibiotic design, resistance to -lactam antibiotic is a serious clinical problem,
1

particularly in immunosuppressed patients and in hospital acquired infections. The most
common mechanism of resistance is the production of -lactamases.These antibiotics
mimic the natural substrate of transpeptidase, which is the pentapeptide chain attached to
the peptidoglycan layer. The peptidoglycan layer is found within the cell wall of both
gram positive and gram negative bacteria. It is composed of a sugar polymer backbone
with peptide linking sugar chains together. Transpeptidase is the enzyme responsible for
these cross-links. In the presence of -lactam antibiotics, transpeptidase is inactivated by
covalent modification of the site. The lack of cross-links in the peptidoglycan layer
causes the cells to lyse due to internal osmotic pressure. [5]
Bacteria have produced four classes of -lactamases to combat -lactam
antibiotics. Three of these classes, A,C, and D, use serines as the nucleophile that cleaves
the -lactam bond. The serine -lactamases have a clinically viable inhibitor and display
narrow substrate specificity. The last class, B, uses a zinc-bound hydroxide as the
nucleophile. This class has wide substrate specificity with activity towards the three
varieties of -lactam antibiotics. The B class is further subdivides into three subclasses
(B1, B2, and B3) based on amino acid sequence homology and substrate preference. [2,
6] Clinically viable inhibitors of serine -lactamases, such as clavulanic acid, sulbactam,
and tazobactam, are used in combination with -lactam antibiotics to combat resistant
bacterial strains. However, metallo--lactamases are unaffected by these inhibitors. To
date, no clinically viable inhibitors have been produced against metallo--lactamases. [6]
Without a viable inhibitor and the wide substrate specificity, metallo--lactamases are an
important target in combating bacterial antibiotic resistance.
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The first subclass, B1, is the largest family and contains the best studied metallo-lactamases. Members of this group include CcrA[7, 8] from Bacillus fragilis and BcII
[9-11]from Bacillus cereus. The preferred substrate for this class is penicillins, though
they display activity with all three types of-lactam antibiotics. With a single equivalent
of zinc (II) they show 70% activity. A second equivalent restores full activity. The two
biding sites for the zinc are known as Zn1 and Zn2. The Zn1 (3H) site is composed of
three histidine residues, similar to the active site found in carbonic anhydrase and many
zinc hydrolases. The Zn2 (DCH) site is composed of one histidine, one cysteine, and one
aspartate residues in addition to a terminal water. The two zinc sites are bridged by a
hydroxide ion. This bridging hydroxide is believed to be the nucleophile that hydrolyzes
the lactam bond.
The second subclass, B2, requires only a single equivalent of zinc to achieve full
activity. Additional equivalents inhibit the enzyme's activity. Prominent members of this
class are ImiS [12] from Aeromonas veronii and CphA [13] from Aeromonas
hydrophillia. Subclass B2 utilizes carbapenems as its preferred substrate. The active
equivalent of zinc occupies the Zn2 site of the typical metallo--lactamase active site with
one histidine, one cysteine, and one aspartate coordinating the metal ion. The second
metal binding site is disrupted by a mutation in the Zn1 site, where one of the metal
binding histidines is replaced by a nonbinding asparagine. The second equivalent of zinc
coordinates between a methionine located in a nearby loop and one histidine ligand. [14]
The third subclass, B3, contains the enzymes L1 [15, 16] from Stenotrophomonas
maltophilia and Gob-18 [17] from Elizabethkingia meningoseptica. Subclass B3 prefers
cephalosporins as its preferred substrate, though it retains activity towards most varieties
3

of -lactam antibiotics. In most cases, one equivalent of zinc provides 70% activity and
the second equivalent restores full activity. The active site is similar to subclass B1 with
the cysteine of site Zn2 (DHH) altered to a histidine. Previous studies suggest the active
site is populated sequentially with the Zn1 (3H) site becoming populated in advance of
the Zn2 (DHH) site. Gob-18 is classified as a B3 enzyme based on sequence homology
and substrate specificity, however Gob-18 only requires one equivalent of metal for full
activity. It contains a similar point mutation to the B2 subclass, where a Zn1 (3H) site
histidine is altered into a glutamine. Unlike the B2 subclass, this enzyme is not inhibited
by additional equivalents of metal ions.

Metallo--Lactamase Superfamily
The  fold appears in more than just the metallo--lactamase enzymes. This
folding motif is more prevalent in prokaryotes than in eukaryotes. Members of this super
family include: glyoxalase 2 (GLX2) [18], a detoxification enzyme that is found in
bacterial, plant, and animal cells; zinc-dependent phosphodiesterase [19] (ZiPD) from
Eschericia coli, a tRNase Z homolog; rubredoxin:oxygen oxidoreductase [20] (ROO)
from Desulfovibrio gigas, a dioxygen reduction enzyme; acyl-homoserine-lactone
lactonase [21-23] (AHLlac) from Bacillus thuringensis, which hydrolyzes extracellular
lactones used for quorum sensing; methylparation hydrolase [24] (MPH) from
Pseudomonas sp., which degrades the organophospate pesticide methyl parathion;
phosphorylcholine esterase [25] (Pce) from Streptococcus pneumoniae, which hydrolyzes
the phosphorylcholine residues from teichoic and lipoteichoic acids; and alkylsulfatase
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[26] (SDSA1) from Pseudomonas aeruginosa, which degrades and metabolizes sodium
dodecylsulfate. The metal binding site in these enzymes is similar to a B3 metallo-lactamase, but includes a carboxylate residue that bridges the two metals. These enzymes
use two equivalents of metal for their activities, but the identity of those metals vary from
enzyme to enzyme. AHL lactonase uses zinc exclusively. Glyoxalase 2 uses a
combination of iron and zinc, as well as manganese in plants. The ROO site uses two
irons and includes an carboxylate in the place of a histidine in the Zn1 (3H) site. These
enzymes are responsible for a wide variety of reactions, but many of them are produced
in response to substances that are toxic to the host cells.

Metal Binding
The metal binding behavior of metallo--lactamases of the three subclasses have
been studied, but the mode of metal binding is still disputed. It has been discussed that
the only biologically relevant form is the monozinc form. All subclasses of metallo-lactamases are active with a single equivalent of metal. Studies have shown that the first
equivalent of metal goes to the Zn1 (3H) site of B1 [27, 28] and B3[29] enzymes and to
the Zn2 (DCH) side of the B2 [13, 14] subclass. With all three subclasses performing
similar chemistry and retaining activity with a single equivalent of metal, this form is
capable of accounting for in vivo activity. Other studies have suggested that the di-zinc
form is the biologically relevant form, but that upon release of product that one metal is
removed from the active site. [30]

5

The metal-binding behavior of metallo--lactamases could follow three schemes,
which are dependent on the binding constants for the two sites. If the binding constants
are more than an order of magnitude different, the binding process would follow a
sequential process with metals binding to the tighter binding site before populating the
second looser site. Greater disparities between the binding constants would result in one
site dominating the initial site bound. As the binding constants of the site become
equivalent, both sites would be populated simultaneously resulting in a random
arrangement of metals. In the random arrangement the four population states of the
enzymes (empty, Zn1 bound, Zn2 bound, and fully loaded) could be present at the same
time. A third possibility is cooperative binding. In this scheme, the addition of the first
equivalent of metal increases the binding affinity of the second site. The second site
becomes preferentially populated instead of the first site of another protein molecule.
This produces a population that is either fully loaded or apoenzyme, with low quantities
of the mono-substituted form.
The metal binding behavior has been studied for a member of each of the three
subclasses. Only x-ray absorption spectroscopy and x-ray diffraction can study the metal
site of the native enzyme, so metal substitution was used to supplement native enzyme
studies. The substitution of cobalt for the zinc is commonly used to produce enzymes
with more favorable spectroscopic properties. The substitution exhibits similar activities
to the native form and will generally adopt the same coordination number and geometry.
Four techniques provide information specific to the metal binding to the active site. The
first applies to the native, zinc-containing enzyme, but all three can apply to cobaltsubstituted enzyme. The primary means of studying the metal-binding behavior of the
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native enzyme is through x-ray absorption spectroscopy, which will provide information
about coordination number, bond length, and the identity of the attached ligands. This
technique allows for direct comparison between the zinc and cobalt-substituted forms.
The other two techniques are only applicable to the cobalt-substituted form of the
enzyme. UV-visible spectroscopy can suggest the coordination number and the presence
or absence of a ligand-to-metal charge transfer band is indicative of cobalt-sulfur bonds.
Paramagnetic 1H NMR may also be used to look at the metal binding site. The protons of
metal-bound residues have their chemical shifts altered by the presence of the unpaired
electrons on the cobalt. The  protons on cysteine residues and the protons on the
histidine rings have different chemical shifts and the histidine protons are solvent
exchangeable. The fourth technique that can be useful in identifying the metal binding
site in cobalt-substituted enzymes is EPR spectroscopy, which is sensitive to the
geometry about a paramagnetic metal. Large changes in the active site will result in
different spectral features; accordingly it is possible to tell if a single species or multiple
species populate the active site. In this way it is possible to distinguish between the
sequential and random/cooperative models of metal binding. With this technique,
modeling the spectra will suggest coordination number for a given species. Included in
the model is a measure of the rhombicity of the site. This value increases to a maximum
of 1/3 the zero field splitting. At the maximum, the suggest coordination number is five
and at the minimum the coordination number favored is six. The four techniques are
complementary and the information that is discovered builds a structural model for the
active site.
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Subclass B1 is the most widely studied subclass with two representative members
(BcII and CcrA) that have been studied spectroscopically. As previously mentioned,
these two enzymes have a binuclear active site that requires 2 equivalents of zincs (II) for
full activity. The first site contains three histidines and a hydroxide bridging the metals.
The second site contains one histidine, one aspartic acid, one cysteine, a terminal water,
and the bridging water. The two sites are very different from each other and provide three
criteria for distinguishing the sites. The presence of the cysteine ligand is identifiable in
all three of the listed techniques, through the Zn-S bond by x-ray absorption
spectroscopy, LMCT band in the UV-visible spectroscopy, and the -protons by NMR.
The number of histidines can be monitored through EXAFS and paramagnetic 1H NMR.
More subtle is the coordination number which is four in the Zn1 (3H) site and five in the
Zn2 (DCH) site, which the intensity of the l->d spectral bands and the intensity of EXAFS
oscillations can suggest.
For CcrA, studies have been conducted on the zinc and cobalt forms of both the
mono- or di-substituted enzymes. With a single equivalent of zinc added, the EXAFS
analysis shows a coordination number of four nitrogens or oxygens with three of those
identified as histidines. [31] EXAFS of dizinc CcrA is best fit by 4 nitrogen or oxygens
ligands, half a sulfur ligand, half of a carboxylate carbon, two histidines, and a Zn-Zn
distance of 3.42 Å. These fits correspond to a sequential binding model, where the first
equivalent of zinc occupies the Zn1 site and the second equivalent forming the bridged
species seen in the crystal structure. The EXAFS of the mono- and di-cobalt-substituted
enzymes are similar to each other, but distinct from the Zn enzymes. They both fit to five
nitrogen/oxygen and two and a half histidines. There is no improvement of the fit upon
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addition of a sulfur ligand. Likewise, the cobalt-cobalt distance is not apparent, which
suggests that there is no bridging hydroxide/water between the metals. The higher
coordination number, five compared to four and four and a half, likely reflects the
adoption of additional solvent molecules. However, other spectroscopic techniques
suggest that the first equivalent of cobalt occupies the Zn1 site. [28] In the UV-visible
spectra the LMCT band does not appear until there is more than one equivalent of cobalt.
Additionally, the paramagnetic 1H NMR shows no evidence of the  protons until the
second site begins to be filled. The additional information suggests that the cobaltsubstituted form of the enzyme similarly displays sequential binding, but the sites are not
identical to the Zn enzymes. The EPR of the CcrA shows that the one equivalent and two
equivalent species are distinct suggesting that the site builds sequentially. The dicobalt
species is composed of two separate species one of which displays the same features as
the monocobalt CcrA. The suggest coordination number is five or six which is consistent
with the EXAFS observation of added solvent ligands. The addition of an extra solvent
molecule and the lack of a bridge suggests that the two forms do the same reaction from
different starting points.
Another member of the subclass B1 (BcII) shows a different trend from CcrA.
Preliminary studies with UV-visible and NMR spectroscopy suggest that from small
additions of cobalt to apo BcII results in some cobalt-sulfur bond formation. [32] In the
UV-visible spectra, the LMCT band appears as the initial equivalents of metal are added,
which continues to grow up to two equivalents. NMR spectra remain unchanged from the
lowest quantities of cobalt through the second equivalent. The EPR of cobalt-substituted
BcII shows that at substoichiometric equivalents of metal, multiple species of cobalt can
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be found. There is also evidence that this species will form a bridged species because of a
deviation of spin density attributed to spin-coupled di-cobalt sites. Later in this work,
EXAFS analysis will explore the metal binding behavior of BcII with cobalt as well as
with the native zinc.
The representative member of subclass B2 that has been extensively probed is
ImiS. There is currently no crystal for this enzyme, but another member of this subclass
CphA has been crystallized. [13] This crystal structure shows that the single equivalent of
zinc occupies the Zn2 (DCH) site. Spectroscopic studies have been consistent with this
picture. Native ImiS was characterized by EXAFS and has three nitrogen/oxygens, one
sulfur, with one histidine. [14] All three techniques have been used to look at cobaltsubstituted ImiS. EXAFS analysis is best fit by 5 nitrogen/oxygen with one histidine. [27]
The addition of a sulfur shell does not significantly improve the fit residual, but the
presence of the sulfur can be seen by the presence of  protons in the NMR and by the
presence of the cobalt-sulfur LMCT band. [33] The inhibitory second equivalent of metal
has also been studied by EXAFS. The second equivalent of zinc binds to a site similar to
the first. The average of the two sites is three nitrogen/oxygen and one sulfur with one
histidine. The enzyme contains no additional cysteine residues in the active site, but a
methionine is present in a mobile loop near the site. With metal bound, the loop's
mobility is hindered and the enzyme is inhibited. The mutation of the methionine to a
nonbinding ligand removes inhibition of additional equivalents of zinc.
The member of subclass B3 that has been best characterized is L1. This enzyme
has been studied with the four techniques detailed previously. In most ways, it is similar
to the subclass B1 enzyme CcrA, though it lacks the diagnostic sulfur ligand. The first
10

equivalent of metal occupies the Zn1 (3H) site with the second equivalent completing the
binuclear site. [29] The cobalt form of the enzyme displays a tendency to higher
coordination number than the corresponding zinc form, which suggests that each site
gains a solvent molecule. [27] This would place the coordination at five and six for the
Zn1 and Zn2 sites respectively. The location of the first metal site was inconclusive via
the EXAFS fits, but the number of histidine peaks in the NMR spectrum established that
binding is sequential with the metal occupying the Zn1 (3H) site. The metallo-lactamase Gob-18, is placed within subclass B3 based on its substrate specificity and
sequence homology, but its metal binding behavior is dramatically different from L1. As
mentioned earlier, Gob-18 is a mononuclear enzyme that requires only one zinc for full
activity. [17] An active site residue has been modified from a histidine in the Zn1 site
(3H) into a glutamine, which disrupts that binding site. This enzyme binds the zinc at the
Zn2 site (DHH), in a similar manner to the B2 enzymes.

Mechanism
Metallo--lactamases are useful to the bacteria because they deactivate -lactam
antibiotics. The reaction they catalyze is the hydrolysis of the lactam bond, breaking
open the four-membered ring. The ring opening reaction eliminates the inhibition of
transpeptidase and allows for the creation of the bacterial cell wall. The four-membered
ring is stable at physiologically relevant pH, but the presence of metal activates a water
molecule for the nucleophilic attack.
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The evidence on the mechanism of the metallo--lactamases is only modest.
Structures of resting and product-bound complexes have been studied through
crystallographic, [13, 16, 34-36] spectroscopic, [8, 12, 14, 29, 32, 33, 37-50] and
computational [51-62] techniques. This provides two steps in the overall mechanism. The
intervening steps have been studied in two cases. The hydrolysis of nitrocefin produces a
spectroscopically observable substrate, which has been studied using stopped-flow
kinetics. [40] The second example is a moxalactam intermediate-bound studied with
crystallography. [36] Additionally, computational studies have been conducted in specific
lactamase-substrate pairings. These studies provide additional detail into the mechanism,
but they may only be important to the individual reactions depicted.
The first stage of the mechanism is the substrate binding to the active site. In dimetal active sites, computational and product-bound studies suggest that the -lactam
carbonyl is brought within close proximity to the Zn1 (DCH) site while the carboxylate
on the second ring binds to the Zn2 site. The additional ligand bound to Zn2 puts the zinc
in the less favored five or six coordinate state. The release of the bridging water would
provide for a strong nucleophile in close proximity to the carbonyl of the lactam ring. The
attack of the nucleophile on the electropositive carbon is the next step in the proposed
mechanism. This would cause the amide bond to break homolytically, leaving a lone pair
on the lactam nitrogen. This brings the formal charge of the nitrogen to negative one. The
charged nitrogen may be stabilized in multiple ways. It can form a bond to the nearby
divalent zinc, it may simply be stabilized by the proximity to the positively charged zinc,
or it can extract a proton from the active site water or nearby residues. In any of these
three cases, the reaction product requires the extraction of a proton within the reaction
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mechanism. After the ring opening reaction, the substrate is attached to the active site by
two or three bonds and these connections must be be replaced by solvent and the original
active site must be regenerated.
A spectroscopically observable intermediate of the reaction can be probed using
the specialized -lactam antibiotic nitrocefin. This cephalosporin contains a
dinitrostyrene sidechain. This sidechain extends the conjugation of the six-membered
ring on the cephalosporin core and can form several resonance structures after ring
opening. When this cephalosporin is reacted with a metallo--lactamase, the -lactam
ring is cleaved and a stable intermediate is formed. [40] This intermediate can be studied
using rapid-scanning and stopped-flow UV-visible spectroscopy. The substrate has an
absorbance maximum at 390 nm and the product displays an absorbance at 485 nm.
Unlike other antibiotics however, the hydrolysis of nitrocefin leads to a third absorption
at 665 nm. The third absorption corresponds to an intermediate species, which is formed
rapidly (5 ms) and is more slowly converted to the product (25 ms).
An intermediate of the pairing of L1 with the -lactam moxalactam was studied
by crystallography by Spencer, et. al. [36] This structure shows a ring opened
moxalactam bound to the dizinc active site of L1. In this case, the carboxylic acid that
originated from the amide carbonyl is bound to Zn2 (3H) and both the amide-originated
nitrogen and the secondary ring carboxylic acid is bound to Zn1 (DCH). The distances of
these interactions measured from the crystal structure are 2.4 Å, which are longer than the
bonds to the enzyme residues and the bridging water (2.0Å – 2.1Å). Computational
studies of this same reaction decrease these bonding distances to approximately those of
the enzyme residues. [60] The crystal structure is also missing a portion of the
13

moxalactam, R' has been altered from 1-methyl tetrazole, connected to the antibiotic
through a thioether linkage, to a simple methyl group.
Each of the two mono-substituted metallo--lactamase have shown activity as
well, and are suggested to follow similar mechanisms. In the case of B2 metallo-lactamases, the Zn2 (3H) site is missing. This site's role in the L1 mechanism is providing
the nucleophilic hydroxide, which attacks the lactam carbonyl. This function could be
replaced by an activated solvent molecule. In the case of metallo--lactamases missing
the Zn2 (DCH) site, the function of this site appears to be the binding of the carboxylic
acid of the second ring, which fixes the substrate into the proper orientation. Secondary
interactions in the active site may serve to orient the substrate. These cases lower the
overall activity of the site. In summary, the di-zinc mechanisms are viewed with some
consensus, while the mono-zinc mechanism remain controversial.

Site Plasticity
A trend that is appearing within the metallo--lactamase family is the versatility
of the site. The system can display reactivity in all three of the metal containing forms.
CcrA and L1 display 70% activity with the Zn1 site solely populated. Gob-18 and ImiS
display full activity with the Zn2 site populated. BcII, L1, and CcrA display their full
activities with both sites filled with zinc. Attempts have also been made using site
directed mutagenesis to convert one subclass into another, but have usually resulted in the
desired metal binding behavior with a loss of activity. In the case of the conversion of
BcII into variants that bind only one metal, the second site was removed by mutation of
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binding ligands of the second site. [63] These two enzymes were named 3H-BcII and
DCH-BcII. In both cases, the rate constants of the reaction were several orders of
magnitude lower than wild type. Another case, the attempt to convert Gob-18 into a
'standard' member of subclass B3, was even less successful. An active site glutamine was
mutated into a histidine, which should have restored the Zn1 (3H) site. However, the site
was unable to bind the second equivalent of metal suggesting that the changes to this
enzyme alters secondary interactions that affects the orientation of the metal binding
residues. The activity of the Q116H mutant of Gob-18 was present for all classes of lactam antibiotics. The activity towards penicillin antibiotics was 80% of the native
enzyme, but the activity towards the other two classes was only 25%.
A more successful case was the conversion of BcII into the other two types of
dizinc sites. [64] A BcII-HD mutant was created by the conversion of the active site
arginine into a histidine and the cysteine ligand into an aspartate. These two mutations
mimic the active site of glyoxalase 2. The other mutant was BcII-HS, which mutated the
arginine into a histidine and the cysteine ligand into a serine, which turns the B1 active
site into a B3 mimic. The BcII-HD bound two equivalents of zinc, but the activity
towards all -lactam antibiotics was reduced by two or more orders of magnitude. The
BcII-HS mutant bound two equivalents of zinc and displayed a preference towards
cephalosporins, but was still lower in activity compared to native BcII.
Metallo--lactamses are able to react with their chosen substrate under a wider
variety of conditions. It functions as a zinc hydrolase from a wide variety of starting
points. The site is functional can be active with metal populating either the Zn1 or the
Zn2 sites and many of the individual members are active over a broad spectrum of 15

lactam antibiotics. Also, the mutation of point residues in the active site can interconvert
subclasses to some extent.

Summary
The zinc-containing metallo--lactamase enzymes are an important family of
enzymes to understand. Their presence among bacteria is continuing to move into more
and more virulent strains and unlike the serine lactamases, they remain without a
clinically viable inhibitor. With the wide ranging effectiveness of the metallo-lactamases, the need to understand their active site structure and mechanism in greater
depth becomes more important. This work will explore in greater depth the metal binding
behavior and reactivity of metallo--lactamase enzymes.
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Figure 1-2: Reaction of-lactamases
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Figure 1-4: Proposed Reaction Mechanism for L1
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Figure 1-5: Structure of Nitrocefin
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Figure 1-6: Structure of Moxalactam (Latamoxef)
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Chapter II
X-Ray Absorption Spectroscopy

Introduction
X-ray absorption was first observed since the 1920’s [1, 2] with the discovery of
the photoelectic effect, but it wasn’t until the 1970’s with the development of synchrotron
sources and the development of EXAFS theory [3-8] that the full potential of x-ray
absorption spectroscopy (XAS) was demonstrated. The high intensity radiation with a
wide spectral distribution allowed for the study of dilute samples. Of particular interest
are non-crystalline metal containing biological samples, which are only available at low
concentrations.
X-ray absorption spectroscopy measures the effect of core electrons being emitted
after the absorption of incoming light of the appropriate wavelength. X-ray absorption
has a threshold energy below which there is only modest loss of light intensity and above
which light is absorbed. This threshold is equivalent to the ionization potential. The
spectrum is divided into three distinct regions: the pre-edge, XANES, and EXAFS
regions. In the pre-edge region, the incoming radiation is less than the necessary energy
to disturb the core electrons and results in only background absorption and scattering of
the light. The XANES (X-ray Absorption Near Edge Structure) region consists of
transitions of core electrons to unoccupied bound states and low-lying continuum states.
Most notable is a rise in the absorption coefficient, which is termed the absorption edge.
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The energy of the edge is specific to each element and to the atomic shell from which the
electron is ejected. The edge energy is modulated by the absorbing atom's environment
and the atom's oxidation state. The region of lower energy near the edge corresponds to
core electron excitation to valence levels, and its intensity provides details about the local
symmetry of the absorbing element. The EXAFS (Extended X-ray Absorption Fine
Structure) region extends above 50 to 1000 electron volts from the edge. At these
energies, the core electron is ejected into the continuum where it is scattered off of nearby
atoms, which creates an oscillatory modulation of the absorption coefficient. [9, 10] The
following sections detail the theory of EXAFS and the general methods of data analysis.

EXAFS
The basic concepts behind the EXAFS phenomenon have been described
previously. [9-11] In the EXAFS region, the incoming radiation exceeds the energy
required to excite core electrons into the continuum as a photoelectron. Energy exceeding
the ionization potential is converted to photoelectron kinetic energy. The photoelectron
can be treated as a spherical wave with an equal probability of propagating in any
direction, with kinetic energy (E-E0) and a wavelength defined by the de Broglie relation
(=h/p).

As the photoelectron wave propagates through space, it interacts with

surrounding matter and interferes with the outgoing wave. (Figure 2-2) This
backscattering phenomenaon creates an interference pattern with maxima and minima
that correspond to regions of constructive and destructive interference.
The resulting sinusoidal oscillations are termed EXAFS (Extended X-ray
Absorption Fine Structure). This region of the spectrum provides information on the
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local environment surrounding the absorbing atom. The EXAFS is a sum of sine waves,
each corresponding to a nearby atom scattering the photoelectron wave. Each of the three
defining characteristics of the sine waves correspond to a property of the absorberscatterer pair. The frequency of the sine waves is a measure of the absorber-scatterer (as)
distance. The amplitude of the sine waves correspond to the number and identity of the
scattering atoms. Atoms at a similar distance contribute additively to the obserced sine
wave amplitude. Similarly, heavier scatterers lead to larger amplitude. The phase of the
sine wave is influenced by the photoelectron passing through the electric potential of the
absorbing and scattering atoms. Each atom type has a different electron density and the
phase shift is an indication of the absorber-scatterer pair.
The empirical expression for the EXAFS modulation is shown in Equation 2-1,
where the EXAFS quantity, , is defined.

 (k ) 

  0
0

Eq 2.1

In principle, Equation 2-1 isolates and normalizes the total absorption coefficient, , from
the absorption coefficient of a monoatomic (free atom) absorber, 0. There are difficulties
with direct measurement of 0, which require additional steps to isolate the EXAFS. The
first step is background removal below the edge, which requires the subtraction of a
polynomial or half-Gaussian to eliminate the background scattering and absorption from
lighter elements. The second step is to eliminate contribution of 0 above the edge, which
is approximated by fitting a high order piecewise polynomial (spline) to the EXAFS
region. The third and final step is normalization to a calculated function that
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approximates m0. The normalization involves calculation of 0 and corrects for variations
in pathlength or concentration among samples.
For ease of comparison of spectra from different absorbing atoms and to easily
extract distance information it is convenient to convert the EXAFS data from energy (eV)
to the photoelectron momentum vector (Å-1)

k

2π
λ

p
h

2πme ν
h

8π 2 m e
h

2

1 2

E

E0

0.2625 E

E0

1 2

Eq. 2-2

In Equation 2-2,, p, and me are the wavelength, momentum, and the mass of the
photoelectron, respectively. The ionization potential, E0, can be experimentally measured
via photoelectron spectroscopy, but in practice it is treated as a variable by converting the
data to k-space using a fixed E0, then refining the number during the fitting process. The
refined E0 is reported as a shift in the ionization potential (E0). The energies were
converted to k-space using the following values: E0= 9680 eV (Zn) and E0= 7725 eV
(Co). Determination of the energy shifts is described later in this section.
The isolated EXAFS data is then fit to the theoretical expression for (Eq. 2-3)
using a nonlinear least squares algorithm.

 (k )  
s

N s Aas (k ) S c
kRas

2

exp(2 R as /  ) exp(2k 2 as ) sin[2kR as   as (k )]
2

Eq. 2-3

Equation 2-3 is based on single scattering theory. Multiple scattering effects will be
discussed later in this section. In equation 2-3, Ns is the number of scatterers (s) in a
given shell of atoms, Aas(k) is the backscattering amplitude of the absorber-scatterer (as)
pair, σas2 is the mean square deviation of the absorber-scatterer bond length (Ras), φas(k)
is the phase shift, and λ is the photoelectron mean free path, Sc is the scale factor, which
is constant for any absorber-scatterer pair. The sum is taken over all shells of scatterers
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that contribute to the EXAFS. EXAFS oscillation intensity is directly proportional to the
number of scatterers and the back scattering amplitude. The intensity is diminished by a
factor of inverse k, so data are usually presented as a k3 (k). The intensity is also
diminished by the distance between the absorber-scatterer pair, which limits the amount
of structural information to distances approximately 4.0-4.5 Å or less. The scale factor
corrects for errors in the theoretically derived amplitude function and is experimentally
determined by fitting data of known structure.
The next two terms in the EXAFS equation are exponential damping terms. The
first term accounts for the inelastic losses from the photoelectron excited state lifetime,
which has contributions from the hole in the core electronic structure resulting from the
excitation and the photoelectron itself. The second term, known as the Debye-Waller
factor, is associated with deviations of the bond length of the absorber-scatterer pair. The
Debye-Waller factor is composed of two elements: static and dynamic disorder of the
bond. The dynamic component is due to vibrational motions. This motion is temperature
dependent and can be minimized by running the experiments at low temperature. The
static disorder is due to structural variations within the sample.
The remaining term in the EXAFS equation provides the sinusoidal oscillation.
This term contains two components: One provides the frequency, and one the phase shift.
The frequency is directly correlated to the absorber-scatterer bond distance with low
frequency corresponding to short bond distances and high frequencies corresponding to
longer ones. With a Fourier transformation of the EXAFS, the frequencies are converted
to distances appearing as a radial distribution function shifted by the phase shift (ca. ~0.4
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Å) which is due to the photoelectrons passing through the electron clouds of the aborbing
and scattering atoms.
In an effort to eliminate high frequency noise and isolate single shells of atoms, a
Fourier filter is applied backtransforming the data into k-space. The backtransformed data
can then be fit to Equation 2-3 to obtain the contribution from individual shells. EXAFS
data presented here is fit as specified in the figure legends (backtransformed from ca. ~1
to 2

Å for coordinated atoms and 0.1 to 4.0 Å for full characterization). Fits are

conducted using the least-squares engine of IFEFFIT (IFEFFIT is open source software
available from http://cars9.uchicago.edu/ifeffit) that is distributed with Sixpack (Six pack
is available from http://ssrl.slac.stanford.edu/~swebb/sixpack.htm). Data was fit to the
unfiltered data to verify results.
Accurate curve fits require correct amplitude and phase functions for the
backscattered photoelectrons. All amplitude and phase functions were obtained using the
ab initio routines of FEFF 8.10. [12] The scale factor (Sc) and the shift in energy (E0)
for each absorber-scatterer pair were calibrated using experimental EXAFS data of
structurally known compounds. Specifically, Ns and Ras were fixed to values derived
from crystal structures and S0, E0, and σas2 were varied. Models used to calibrate the
following

studies

were

zinc

tetrakismethylimadazole,

ZN(MeIm)4,[13]

zinc

tetramesitylthiolate, Zn(SMes)4, cobalt bis-trispyrazolylborate, Co(Tp)2, and cobalt
tetramesitylthiolate, Co(SMes)4, for Zn-N, Zn-S, Co-N, and Co-S absorber-scatterer pairs
respectively. Optimal values for the scale factors and E0 were: Zn-N Sc = 0.78 , E0 = 21, Zn-S Sc = 0.91 , E0 = -21, Co-N Sc = 0.74 , E0 = -11, and Co-S Sc = 0.85 , E0 = -11
when E0 in equation 2-2 was set to the values mentioned earlier. These optimized values
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were used with samples of unknown structure by keeping Sc andE0 constant and
varying Ras and σas2.
In summary, EXAFS can provide information about the distance, coordination
number, identity and relative disorder of atoms surrounding the absorber, but the
accuracies and precision of each of these values vary. The most accurate of these values
are the distances between the absorber-scatterers with accuracies of

±0.01 Å and

precision of ± 0.005 Å. The identity of the neighboring scatterer can only be determined
to the nearest row of the periodic table, which easily distinguishes nitrogen and sulfur but
is unable to distinguish nitrogen from oxygen. This is a direct result of the dependence of
the phase and amplitude on the sizes of the relative scattering atoms. The resolution of
separating two identical shells of atoms from each other is dependent on the k-range of
the data as shown in Eq. 2-4,
ΔR=

π
2Δk

Eq. 2-4

where R and k are the resolution and k- ranges of the data. [14] The coordination
number has an accuracy of ± 25% which corresponds to ± 1 atoms.
The variables within the EXAFS equation are highly correlated. The amplitude is
dependent on the coordination number, scatterer identity and disorder of the absorberscatterer pair. A large Debye-Waller factor may indicate the coordination number is too
high or the shell is composed of two separate shells of atoms. The scale factor also
contributes to amplitude, and a low Sc will over estimate the coordination number. The
phase term is dependent on the absorber-scatterer distance and the scatterer identity,
which complicates the identification of scattering atoms. With these correlations, care
must be exercised to produce an accurate fit.
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The number of independent data points, Nidp in a data set is defined by Eq. 2.5.
[15]

N idp 

2kR



2

Eq. 2-5

This equation is a measure of the total information content present in the data and
represents the maximum number of parameters that can be determined by a fit to the
spectrum. For the first shell of scatterers in a typical EXAFS spectrum, Nidp can vary
from 9 to 12 depending on the width of the peak, DR, and the quality of the data, k.
Five variable parameters are available in Eq.2-3 (Ns, Ras,as2, Sc, E0) for a single shell
of atoms. The typical value of ~10 idp (k ~ 11, R ~ 1.2) allows for a single shell of
atoms to be over-determined. Increasing the number of scattering shells to two, the
maximum number of variables would equal the independent data points. Adding a third
shell, would increase the number of variables beyond the information content of the data,
under-determining the fit. For fits provided in this document, the number of variables per
shell of scatterers was limited to Ras, as2. In all cases, the number of variable parameters
never exceeded the number of independent data points.
The quality of fit is determined in IFEFFIT by a R-factor, defined by Eq. 2-6,
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Eq. 2-6

where Re and Im represent the real and imaginary components of the EXAFS data. [16]
The equation is the sum-of-squares measure of the fractional misfit of the data. This
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'goodness of fit' is not dependent on Nidp, the number of variables, or the measurement
uncertainty. It is only dependent on how well the fit matches the data.

Experimental Techniques

The basic experimental setup employed in collecting EXAFS data has the same
components as a fluorescence experiment. There is a light source, a monochromator, the
sample, and a detector. The light source is the highly collimated, 'white' x-ray radiation
available at the National Synchrotron Light Source. The light is made uniform with a
series of slits. The energy is selected as the beam passes through a double-crystal
monochromator which keeps the outgoing beam parallel to the incident beam. The
intensity of the radiation is measured with a series of ionization chambers I0, I1, and I2.
Energy calibration is achieved by passing a portion of the beam through a metal foil of
the appropriate element. Spectra may be collected either as a transmission (T = ln (I0/I1)
or a fluorescence experiment (F = ln (IF/I0).
The energy range requirement for biological samples (2.5 – 25 keV) can be
obtained with conventional x-ray tubes, a rotating anode, or synchrotron radiation, but the
photon flux at a synchrotron radiation sources make it ideal for metalloprotein studies.
All data reported here were recorded at Beamline X3B at the National Synchrotron Light
Source at Brookhaven National Lab.
Energy selection in this particular setup is accomplished using Bragg reflection
from single crystals (Eq. 2-7).
 hc 
n  n   2d sin 
E
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Eq. 2-7

In Equation 2-7, n is the order of reflection, l is the wavelength, E is the energy of the
diffracted ray,  is the angle between the Bragg planes, and d is the spacing between the
crystal lattice planes. Si(111) crystals are used (d= 3.14 Å) at X3B in a double crystal
arrangement, allowing the reflected beam to exit parallel to the incident beam. Tuning the
energy is accomplished by rotating the crystals relative to the incident beam.
For flat crystal monochromators, the energy resolution is given by Eq. 2-8,
E  E   cot 

Eq. 2-8

where  is the Bragg angle at energy E and  is the spread in x-rays passing through the
monochromators. [11, 17] For synchrotron radiation,  is the vertical collimation of the
entering x-ray beam. With this relationship, the vertical aperture is inversely proportional
to the energy resolution. Thus, it is highly desirable to operate with as small of a vertical
aperture as possible to maintain adequate photon flux. Additionally, moving to a smaller
d-spacing (i.e., Si(220), 1.92Å) will increase energy resolution.
The monochromator selected energy is not the only reflected energy. Higher order
harmonics (n>1) are also reflected. Harmonic rejection can be accomplished by either
detuning or use of an inline mirror. The first method involves placing the crystals slightly
nonparallel with respect to one another. This method will reduce the harmonic intensities
to negligible levels while reducing the primary energy by ~50% of the original intensity.
The second method requires the use of a nickel coated mirror which reflects the primary
energy. However, this method cannot be used with all elements due to the nickel coating.
In particular, cobalt and nickel spectra are distorted in the region where the mirror
absorbs. [18, 19]
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As noted earlier, X-ray absorption data may be collected either as transmission or
fluorescence spectra. With high concentration samples (solids or solutions containing
greater than 10 mM of the absorbing element), the transmission setup is optimal. The
absorption coefficient, , can be measure by Beer's law, Eq. 2-9,
A A0 exp

μx

Eq. 2-9

where x is sample thickness, A0 is the intensity of incident x-rays, and A is the intensity
of transmitted x-rays. The intensities of the x-rays are collected as a function of energy
(ln A/A0 vs. E). The x-ray intensities are measured using gas ionization detectors, which
consist of x-ray transparent windows and two charged plates filled with an inert,
ionizable gas. X-rays pass through the chamber, ionize the gas, and generate a current
which is proportional to the x-ray intensity. The current is amplified and measured using
a VDC.
Dilute materials (~ 1 mM) were analyzed by fluorescence. At energies above the
K-edge, the ionized atoms relax by emitting a fluorescent x-ray photon.

This

fluorescence is created when the hole left by the photoelectron is occupied by an electron
from the n = 2 level emitting fluorescence (K fluorescence). The energy of this
fluorescence is lower than that of the absorption edge and can be isolated with a photoncounting detector. The fluorescence is directly proportional to the absorption events, thus
the plot directly mimics the absorption spectrum. This detection method allows for
monitoring dilute systems because only the K fluorescence from the atom of interest is
observed at the detector. All metalloprotein data was collected using a 13-channel solidstate germanium fluorescence detector.
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The protein samples include a glassing agent (i.e., ~20% glycerol) in the aqueous
buffers. Inclusion of the glassing agent prevents the formation of ice crystals. Ice crystals
diffract x-rays dominating fluorescence, which results in unreliable data. Samples were
contained in lexan cells with a mylar tape window and maintained at low (~ 20K)
temperature on a cold finger. Each detector channel each examined, before being
averaged. Those that contained artifacts were excluded from the average. All of the
proteins presented here represent the average the average of 8-16 scans, typically
incorporating 9-11 channels per scan.
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Chapter III
Spectroscopic and Mechanistic Studies on
Metallo--lactamase Bla2 from Bacillus anthracis

The following work was published in Megan J. Hawk, Robert M. Breece, Christine E.
Hajdin, Katherine M. Bender, Zhenxin Hu, Alison L. Costello, Brian Bennett, David L.
Tierney, and Michael W. Crowder. Journal of the American Chemical Society, 2009.
131(30): p. 10753-10762.

The author's contribution to the following discussion was collection, analysis, and
interpretation of the EXAFS on Bla2. Megan Hawk contributed the protein preparation,
NMR spectroscopy, kinetics, and optical spectroscopy. Brian Bennett contributed the
EPR spectroscopy collection and interpretation.

Introduction
Anthrax is a disease that affects cattle and other herbivores and is caused by the
spore-forming bacterium Bacillus anthracis. [1] Anthrax infections in humans lead to
dark pustules on the skin, and are most commonly caused by contact with infected
animals. However, anthrax infections can also be caused by ingestion or inhalation of B.
anthracis spores. The potential for airborne transmission has led to the development of
anthrax as a potential biological warfare agent, [2] and B. anthracis has been labeled as a
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category A bioterrorism agent by the Centers of Disease Control and Prevention (CDC).
[3]
Two significant anthrax outbreaks are on record due to non-environmental
sources. The accidental release of military-grade anthrax in Sverdlovsk, USSR in 1979
caused at least 62 deaths. [4] In October, 2001, the Washington, D. C. Processing and
Distribution Center of the U.S. Postal Service, and several congressional offices, were
contaminated with a highly-processed form of anthrax from the Ames strain. More than
2,000 workers were exposed, leading to 22 infections and 11 deaths. [3] Currently, the
CDC recommends a 60 day antimicrobial regimen of ciprofloxacin, doxycycline, or
amoxicillin

for

anthrax

infections.

[2]

Cephalosporins,

trimethoprim,

and

sulfamethoxazole are not prescribed, due to the suspected resistance to these drugs.
Recently, the Sterne strain of B. anthracis has been reported to produce both a class A
(Bla1) and a class B (Bla2) -lactamase. [5]
Currently, over 50% of the antibiotics prescribed by physicians are β-lactamcontaining compounds, such as penicillins, cephalosporins, and carbapenems. [6]
However, an increasing number of bacterial pathogens show resistance to -lactam
antibiotics, threatening their efficacy into the future. The most common pathway for
resistance is the bacterial production of β-lactamases, which hydrolyze the fourmembered ring in β-lactam antibiotics, rendering them ineffective. [7, 8] To date, over
400 -lactamases have been described, and these enzymes have been classified into four
subgroups (A-D). [8] While exhibiting different kinetic and inhibition properties, all
group A, C, and D -lactamases utilize an active site serine to perform nucleophilic
attack on the substrate. The serine -lactamases (SLs) are the most clinically-
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significant, and there are some clinical inhibitors that are active towards a majority of the
enzymes in these groups. [8]
In contrast, the group B -lactamases, often referred to as metallo--lactamases or
MLs, require 1-2 Zn(II) ions for catalytic activity.[9, 10] Approximately 40 MLs have
been reported, leading to their further classification into 3 subgroups. [11] The B1
enzymes require 1-2 Zn(II) ions for full activity, and prefer penicillins as substrates. They
bind one Zn(II) in the Zn1 (or 3H) site, which is made up of His116, His118, His196, and
a solvent-derived ligand that bridges the two metal ions, and one Zn(II) in the Zn2 (or
DCH) site, made up of His263, Asp120, Cys221, the bridging solvent, and a terminallybound water. Subclass B1 is represented by BcII from Bacillus cereus, CcrA from
Bacteroides fragilis, and IMP-1 from Pseudomonas aeruginosa. The B2 enzymes,
represented by CphA from Aeromonas hydrophila and imiS from Aeromonas sobria,
require only one Zn(II) for full activity, prefer carbapenems as substrates and bind the
catalytic Zn(II) in the Zn2 site. The B3 enzymes generally require two Zn(II) ions for full
activity, prefer cephalosporins as substrates, bind one Zn(II) in the canonical Zn1 site and
one Zn(II) in a modified Zn2 site where Cys221 is replaced by His121, and are
represented by L1 from Stenotrophomonas maltophilia and FEZ-1 from Legionella
gormanii. Recently, a new member of the B3 subclass has been reported, and unlike its
brethren, GOB from Elizabethkingia meningioseptica is a mono-Zn enzyme that binds
metal at the Zn2 site. [12]
Although the Sterne strain of B. anthracis has not caused the kind of human
infection that the Ames and Sverdlovsk strains have, transfer of the Bla2 gene to a more
pathogenic Bacillus is expected to be facile. Bla2 shares 89% sequence identity and 92%
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sequence homology with BcII, [5, 13] and it would seem that all structural, mechanistic,
and computational studies already reported for BcII would be applicable to Bla2. In spite
of having very similar amino acid sequences, steady-state kinetic constants reported for
Bla2 and BcII are different, [5, 14] and several active site amino acids (IIe39, Thr182 and
Gly151) in BcII are not conserved in Bla2. In addition, there is conflicting data on BcII,
[15-18] and it is not clear which set of data, if either, applies to Bla2.
We report here detailed studies to characterize recombinant Bla2 from B.
anthracis. The metal content of the enzyme was ascertained with ICP-AES, and the
steady-state kinetic constants of various analogs of the enzyme, with a range of
substrates, were determined. To probe the structure of Bla2, the mono- and di-Co(II)
analogs were prepared and characterized by UV-Vis, 1H NMR, EPR, and EXAFS
spectroscopies. These studies are complemented by EXAFS of the mono- and di-Zn(II)
enzymes. Together the data demonstrate that metal binding by Bla2 follows distinct
pathways, dependent on the identity of the metal ion (Co(II) or Zn(II)), and that the
reactivity of the Zn- and Co-containing enzymes are quite different.

Experimental Procedures
Materials. The pET24bOmpA-Bla2 over-expression plasmid was generously
supplied by Professor Timothy Palzkill of the Baylor School of Medicine, [5] and E. coli
strain BL21(DE3) was purchased from Novagen, Madison, WI. A Minitan II concentrator
system was purchased from Fisher Scientific, Pittsburgh, PA, with 1000 NMWL plates
from Millipore, Bedford, MA. All chromatographic steps were conducted with a fast
protein liquid chromatography (FPLC) system purchased from Amersham Pharmacia
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Biotech. Nitrocefin and cefaclor were purchased from Becton Dickinson and Sigma,
respectively. Meropenem and imipenem were donated by Zeneca Pharmaceticals,
Wilmington, DE and Merck and Co., Rahway, NJ, respectively.
Over-Expression, Purification, and Biochemical Characterization. The pET24bOmpA-Bla2 plasmid was transformed into E. coli BL21(DE3) cells via electroporation.
Colonies from the transformation were used to inoculate 10 ml of LB medium containing
25 g/ml kanamycin, and the culture was shaken overnight at 37 C. The overnight culture
was used to inoculate 4x1L of LB medium containing 25 μg/ml kanamycin at 37 C,
which were shaken at 37 C until reaching an optical density at 600 nm of 0.75-0.85.
Protein production was induced with 1 mM isopropyl-β-D-thiogalactopyranoside (IPTG),
and the cultures were allowed to shake overnight at 25 C.
The resulting cells were centrifuged (10 min at 7500 xg), and the supernatant was
collected. The protein solution was kept on ice and concentrated with a Minitan II system
equipped with 1000 NMWL plates until the volume reached ca. 50 ml. The concentrated
protein mixture was centrifuged (30 min at 14500 xg), and the supernatant was dialyzed
versus 2L of 50 mM Hepes, pH 6.5, overnight at 4 C. The supernatant was centrifuged
(30 min at 14,500 xg) to remove insoluble matter and loaded onto an SP-Sepharose
column (25 ml bed volume), which was pre-equilibrated with 50 mM Hepes, pH 6.5.
Bound proteins were eluted with a 0-1 M NaCl gradient in 50 mM Hepes, pH 6.5, at 2
ml/min. Fractions (6 ml) containing Bla2, as determined by SDS-PAGE, were pooled and
concentrated with an Amicon ultrafiltration cell equipped with a YM-10 membrane.
SDS-PAGE gels were used to ascertain protein purity. The molecular mass of
recombinant Bla2 in 50 mM Hepes, pH 6.5, was determined by MALDI-TOF mass
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spectrometry. Amino acid analyses of Bla2 were conducted by the Protein Separation and
Analysis Laboratory at Purdue University, West Lafayette, IN.
Metal Analyses. The metal content of Bla2 was determined using a Varian Liberty
150 inductively coupled plasma spectrometer with atomic emission detection (ICP-AES).
Bla2 samples were diluted to 10 μM or 20 μM in 50 mM Hepes, pH 6.5. Calibration
curves of five standards (Zn(II), Cu(II), Ni(II), Mn(II), Co(II), and Fe) were used to
quantify the metal ion concentrations in Bla2 samples, as previously reported. [19]
Steady-State Kinetics. Steady-state kinetic studies were conducted at 25 C in 50
mM Hepes, pH 6.5, on a Hewlett-Packard model 5480A diode array spectrophotometer.
The molar absorptivities of the substrates used were Δε485nm = 17,400 M-1cm-1 for
nitrocefin, Δε280nm = -6,410 M-1cm-1 for cefaclor, Δε305nm =

7,600 M-1cm-1 for

meropenem, and Δε300nm = -9000 M-1cm-1 for imipenem. Substrate concentrations ranged
from 10 to 200 μM, and the enzyme concentration was held fixed at ca. 10 nM. Steadystate kinetic constants were determined as described previously. [19]
Preparation of apo-Bla2. Bla2 (1-2 ml of 1 mM as-isolated enzyme) was dialyzed
versus 4x2L (12 hours each) of 15 mM Hepes, pH 6.5, containing 10 mM EDTA at 4 C.
EDTA was removed by dialysis versus 2x2L of Chelex-treated, 15 mM Hepes, pH 6.5,
containing 150 mM NaCl, followed by 2x2L of Chelexed 15 mM Hepes, pH 6.5,
containing 100 mM NaCl, for 6 h each, at 4 C. After the last dialysis step, the protein
solution was centrifuged (30 min at 14,500 xg) to remove precipitated protein and then
concentrated by ultrafiltration to 1-2 ml. The resulting solution was passed through a
Sephadex G-25 column, using Chelex-treated 15 mM Hepes, pH 6.5, containing 100 mM
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NaCl, as eluent. Fractions were collected, and samples containing Bla2 were pooled and
concentrated, prior to the determination of metal content by ICP-AES.
UV-Vis Spectrophotometry. Apo-Bla2 (ca. 1 mM) in Chelexed 15 mM Hepes, pH
6.5, containing 100 mM NaCl was titrated with CoCl2 (Strem Chemicals, 99.999 %).
Samples of Bla2 with 1 or 2 eq of added Co(II) were incubated on ice for 5 min. before
being centrifuged (10 minutes at 14,500 x g) to remove precipitated protein. Difference
spectra were obtained by subtracting the spectrum of apo-Bla2 from those of the Co(II)added samples.
Stopped-Flow UV-Vis Studies. Diode array UV-Vis spectra were collected (200 –
700

nm)

at

4

C

on

an

Applied

Photophysics

SX18-MVR

stopped-flow

spectrophotometer. The buffer used in these experiments was 50 mM Hepes, pH 6.5, and
the substrates were nitrocefin, cefaclor, and imipenem. Substrate concentrations ranged
from 10 to 50 μM, and the concentration of 1Zn-Bla2 was held constant at 20 μM. All
experiments were conducted in triplicate, and the data presented here represent the
average of these multiple data sets. Stopped-flow absorbance data were converted to
concentrations as previously described, [20] and the data were corrected for the
instrument dead time of 2 ms. The resulting progress curves were fitted to single
exponentials, and the resultant values of kobs were plotted against substrate concentration.
When using nitrocefin as substrate, these plots were hyperbolic and fitted to kobs =
K1[S]k2 / (K1[S] + k-2), as previously described. [21] When using cefaclor and imipenem
as substrates, these plots were linear and fitted to kobs = k1[S] + k-1. The progress curves
were simulated using KINSIM, as previously described. [22, 23] Dynafit was used to
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verify the simulations, [24] and ProK was used to obtain errors for the rate constants, as
previously described. [22]
EPR spectroscopy. EPR spectra were recorded using a Bruker EleXsys E600 EPR
spectrometer equipped with an Oxford Instruments ITC4 temperature controller and an
ESR-900 helium flow cryostat. A Bruker ER-4116DM cavity was used, with a resonant
frequency of 9.63 GHz (in perpendicular mode) and 10 G (1 mT) field modulation at 100
kHz was employed. Other recording conditions are given in the legend to Figure 4.
Computer simulations of EPR spectra were carried out using the matrix diagonalization
program Xsophe [25] (Bruker Biospin GmbH) assuming a spin Hamiltonian H = g.B.S
+ S.D.S, where S = 3/2 and D > 0 corresponds to an MS = |1/2 ground state Kramers’
doublet, as previously described. [22, 26, 27]
NMR Spectroscopy. 1H NMR spectra were collected at 298 K on a Bruker Avance
500 spectrometer operating at a proton frequency of 500.13 MHz. Samples of Bla2 in
either 10 % or 90 % H2O were 1 mM in Chelex-treated, 15 mM Hepes, pH. 6.5,
containing 100 mM NaCl. All samples were incubated for 30 min on ice after D2O
addition and centrifuged, before being placed in the NMR tube. Spectra were collected
using a presaturation pulse sequence (zgpr) for water suppression, a recycle time of 41
ms, and a sweep width of 400 or 800 ppm. Prior to Fourier transformation, the FID was
apodized with an exponential function that resulted in an additional line broadening of 80
Hz.
X-Ray Absorption Spectroscopy. Samples of Bla2 (~ 1 mM, including 20% (v/v)
glycerol added as a glassing agent) were loaded in Lucite cuvettes with 6 m
polypropylene windows and frozen rapidly in liquid nitrogen. X-ray absorption spectra

55

were measured at the National Synchrotron Light Source (NSLS), beamline X3B, with a
Si(111) double crystal monochromator; harmonic rejection was accomplished using a Ni
focusing mirror. Fluorescence excitation spectra for all samples were measured with a
13-element solid-state Ge detector array. Samples were held at ~ 15 K in a Displex
cryostat during XAS measurements. X-ray energies were calibrated by reference to the
absorption spectrum of the appropriate metal foil, measured concurrently with the protein
spectra. All of the data shown represent the average of ~ 12 total scans, from two
independently prepared samples each. Data collection and reduction were performed
according to published procedures [28] with E0 set to 9680 eV for Zn and 7735 eV for
Co. The Fourier-filtered EXAFS were fit to Equation 1 using the nonlinear least-squares
engine of IFEFFIT that is distributed with SixPack. [29, 30]

 (k )  

N as As (k ) S c
2
exp(2k 2 as ) exp(2 Ras /  ) sin[ 2kRas  as (k )]
2
kRas

(1)

In Eq. 1, Nas is the number of scatterers within a given radius (Ras, ± as), As(k) is
the backscattering amplitude of the absorber-scatterer (as) pair, Sc is a scale factor,

as (k ) is the phase shift experienced by the photoelectron,  is the photoelectron mean
free-path, and the sum is taken over all shells of scattering atoms included in the fit.
Theoretical amplitude and phase functions, As(k)exp(-2Ras) and as (k ) , were calculated
using FEFF v. 8.00. [31] The scale factor (Sc) and E0 for Zn-N (Sc = 0.78, E0 = -21
eV), Zn-S (0.85, -21 eV), Co-N (0.74, -26 eV) and Co-S (0.85, -26 eV) scattering were
determined previously and held fixed throughout this analysis. [28, 32] Fits to the current
data were obtained for all reasonable integer or half-integer coordination numbers,
refining only Ras and as2 for a given shell. Multiple scattering contributions from
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histidine ligands were approximated according to published procedures, fixing the
number of imidazole ligands per metal ion at half-integral values while varying Ras and

as2 for each of the four combined ms pathways (see Table 4). [28, 32] Metal-metal (CoCo and Zn-Zn) scattering was modeled by fitting calculated amplitude and phase
functions to the experimental EXAFS of Co2(salpn)2 and Zn2(sapln)2.

Results
Biochemical Characterization

Overexpression and Purification of Bla2. Previously, Palzkill and co-workers
designed a pET24-based over-expression plasmid that produces an OmpA-Bla2 fusion
protein. [5] The fusion protein is ultimately exported to the outer membrane, where
cleavage of the fusion protein deposits recombinant Bla2 directly into the growth
medium. Using our procedure, 17-23 mg of > 95 % pure Bla2 can be obtained from 1
liter of LB medium (Figure 1). Amino acid analyses indicate an extinction coefficient
(280) of 25,400 M-1cm-1, and the MALDI-TOF MS exhibits an m/z of 24,249 amu
(25,360 predicted, based on the amino acid sequence). [13] Metal analysis demonstrates
the as-isolated enzyme contains 1.0 + 0.2 equivalents of Zn and < 0.1 equivalent of Co,
Cu, Ni, Mn, or Fe. Incubation of the as-isolated enzyme with a 4-fold excess of Zn(II),
followed by Chelex treatment to remove unbound and loosely bound metal ions, resulted
in an enzyme that tightly bound 1.4 + 0.1 eq of Zn. In general, the presence of excess Zn
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in the medium destabilized the dilute enzyme, often resulting in irreversible precipitation;
similar effects were not observed at higher (> 0.5 mM) concentrations.
Steady-State Kinetics of Bla2. Previous kinetic studies by Palzkill, et al were
conducted in 50 mM Hepes, pH 7.5, containing 50 μM Zn(II) and 20 μg bovine serum
albumin (BSA). [5] In initial attempts to measure steady-state kinetics under these
conditions, we found the enzyme to be unstable. Inclusion of BSA did not stabilize the
enzyme in our hands. However, Bla2’s predicted pI of 7.6 led us to speculate that
lowering the pH from 7.5 would stabilize the protein. Reproducible steady-state kinetic
data was obtained at pH 6.5 in 50 mM Hepes. It is important to bear in mind that the
steady-state kinetic buffers contain ~ 100 nM Zn(II), [33] even if the buffers are Chelextreated, while the assayed enzyme concentration is 1-10 nM. Given this, it is difficult to
state with certainty the exact metal content of the Zn-Bla2 analogs in Table 2. Within
theses limits, as-isolated Bla2, which most closely resembles the mono-zinc enzyme,
hydrolyzed nitrocefin, imipenem, cefaclor, and meropenem with kcat values ranging from
24 to 92 s-1 and Km values ranging from 25 to 110 M (Table 1).
Apo-Bla2 was prepared by dialysis against EDTA, followed by exhaustive
dialysis to remove residual EDTA (see Materials and Methods). Apo-Bla2 prepared in
this way contained no detectable Zn, Co, Mn, or Fe, as indicated by ICP-AES. Direct
addition of 1 or 2 eq of Zn(II) to the apoenzyme gave the 1Zn- and ZnZn-analogs of Bla2
that were used for metal-dependent steady state kinetic studies (Table 2). 1Zn-Bla2
exhibited a kcat of 32 s-1 and a Km of 28 M at pH 6.5 using nitrocefin as the substrate.
The kcat of this enzyme was ca. 30 % less than that of as-isolated Bla2 (Table 1). Addition
of a second eq of Zn(II) (ZnZn-Bla2) resulted in an increase in both kcat and Km, while
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further additions of Zn(II) led to a steady drop in kcat, consistent with the instability of the
dilute enzyme in the presence of excess Zn(II) noted above. The analogous mono- and diCo(II) enzymes (1Co-Bla2 and CoCo-Bla2, respectively) gave steady-state values for
both kcat and Km that were similar to the corresponding Zn enzymes (Table 2).
Stopped-Flow UV-Vis Kinetic Studies. Stopped-flow kinetic studies were
conducted on 1Zn-Bla2 with three substrates (nitrocefin, cefaclor, and imipenem).
Similar studies were not performed on ZnZn-Bla2, due to its instability in dilute
solution. In the reaction of 1Zn-Bla2 (20 μM) with nitrocefin (10 – 50 μM), only two
distinct features are observed: one at 390 nm that decreases with time, corresponding to
loss of substrate, and one at 485 nm that increases with time, corresponding to product
formation (Figure 2). No transitory absorbance was observed at 665 nm, corresponding to
a stable intermediate previously observed in reactions of nitrocefin with CcrA [34] and
L1, [20] but not with BcII. [35] Progress curves at 390 and 485 nm using 25 and 50 μM
nitrocefin were fitted to single exponentials to obtain kobs. A plot of kobs vs. substrate
concentration was hyperbolic, suggesting a rapid-equilibrium, two-step binding
mechanism (Scheme 1). [21] The progress curves were simulated using KINSIM, the
mechanism in Scheme 1, and the rate constants in Table 3 (Figure 2). The King-Altman
method [36] was used to determine theoretical expressions for kcat and Km, based on the
mechanism in Scheme 1, and the resulting steady-state kinetic constants (kcat = 7.4 s-1 and
Km = 62 M) were similar to those determined in steady-state kinetic studies (Table 1).
Stopped-flow kinetic studies were also performed on 1Zn-Bla2 with imipenem
and cefaclor. In these reactions, only the substrates could be observed. Unlike for
nitrocefin, plots of kobs vs. imipenem or cefaclor concentration is linear, suggesting one-
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step binding mechanisms for both substrates (Scheme 2). [36] The resulting progress
curves were simulated using KINSIM, the mechanism in Scheme 2, and the rate
constants in Table 3. The King-Altman-determined theoretical expressions for kcat and Km
give theoretical values for imipenem (kcat = 35 s-1 and Km = 194 μM) and cefaclor (kcat =
15 s-1 and Km = 150 μM) that are similar to those determined by steady-state kinetic
studies (Table 1).

Metal Binding

Optical Spectroscopy. We first examined Co(II) binding by optical titration of
apo-Bla2. The UV-visible difference spectra (Co-bound – apo-Bla2, Figure 3) show the
Cys-S to Co(II) charge transfer transition at 320 nm (ε320 = 608 M-1 cm-1) that is
indicative of metal binding at the Zn2 site, even at 0.5 eq of Co(II). Also apparent at 0.5
eq of Co(II) are the ligand field transitions (500 – 650 nm, ε550 = 218 M-1 cm-1) normally
associated with metal binding at the Zn1 site (Figure 3). Each of these features increases
linearly in absorbance as a function of added Co(II) (Figure 3, inset), suggesting that
Co(II) distributes between the Zn1 and Zn2 sites with minimal difference in affinity. We
were unable to obtain the optical spectrum of Bla2 containing 3 eq of Co(II) because the
protein quickly precipitated, similar to prior observations from Co(II) titrations of CcrA.
[37]
EPR Spectroscopy. EPR spectra from 1Co-Bla2 and CoCo-Bla2 were recorded
under non-saturating, saturating, and rapid-passage conditions and are shown in Figure 4.
The spectra from 1Co-Bla2 (Fig. 4A) and CoCo(II)-Bla2 (Fig. 4B) recorded under nonsaturating conditions exhibited no resolvable rhombicity or 59Co hyperfine structure, and
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were characteristic of 5- or 6-coordinate Co(II) with at least one water ligand. Spectra
recorded at high power and low temperature (Fig. 4D) did not reveal any MS = | 3/2
signals that would indicate tetrahedral Co(II). Slight differences were observed between
the non-saturated spectra of 1Co-Bla2 and CoCo-Bla2. The difference spectrum (Figure
4C) revealed the presence of a second Co(II) species in CoCo-Bla2, indicating at least
some preference for one site over the other, though this could not be quantified.
The rapid passage spectra of 1Co-Bla2 and CoCo-Bla2 (Fig. 4E) were
indistinguishable in form and differed only in intensity, by a factor of 2. This indicates
that the species that is responsible for this spectrum is the same in both 1Co-Bla2 and
CoCo-Bla2, and that twice as much of it is present in CoCo-Bla2 than in 1Co-Bla2.
These data are consistent with either a cooperative binding mechanism or a random
mechanism with similar affinities for the sites, but are completely inconsistent with a
sequential mechanism. Comparison of the normal, non-saturated spectrum of 1Co-Bla2
and the (CoCo-Bla2 - 1Co-Bla2) difference spectrum (Fig. 4C) shows that the spectrum
of 1Co-Bla2 is sharper in the g region, around 2000 G (200 mT). The derivative of the
rapid passage spectrum (of either 1Co-Bla2 or CoCo-Bla2) is, in turn, sharper still than
that of 1Co-Bla2; the former more likely represents a single chemical species and
provides some direct evidence that the signal from 1Co-Bla2 contains more than one
species.
Taken overall, then, the EPR data indicate that the signal from 1Co-Bla2 is likely
due to two components, one of which can be isolated by recording the spectrum under
rapid passage conditions for that signal, and another that is similar in line shape but could
not be deconvoluted. Approximately 85% of the signal from CoCo-Bla2 consists of
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Co(II) in the same environments, with the same distribution among those environments,
as in 1Co-Bla2. These data indicate a binding mechanism that is largely either random or
cooperative. A minor fraction of the Co(II) spin density in CoCo-Bla2, 15%, appears
either to (i) indicate Co(II) that resides in a third, distinct environment or (ii) represent a
slight difference in the distribution of Co(II) between two binding sites, or else (iii) is
indicative of a broadening mechanism due to weak spin-coupling between Co(II) ions
that is more pronounced in CoCo-Bla2 than in 1Co-Bla2. While the latter possibility
would suggest random binding to sites with similar affinities, rather than cooperative
binding, there was no additional evidence from parallel mode EPR (B0|B1, not shown)
for weak magnetic coupling between the two Co(II) ions in CoCo-Bla2.
NMR Spectroscopy. The 1H NMR spectrum of CoCo-Bla2 in 10 % D2O shows
five downfield shifted resonances between 35 and 85 ppm (Figure 5). The spectrum is
nearly identical in appearance to that previously reported for di-Co BcII, [15] where each
peak was assigned to a single proton, despite significant differences in linewidth and
intensity. The 1H NMR spectrum of Bla2 containing one eq of Co(II) is identical to that
of CoCo-Bla2, although of lower signal-to-noise (Figure S8). In 90 % D2O, four of the
resonances of CoCo-Bla2 (78, 65, 49, and 44 ppm) disappear. With analogy to the crystal
structure of BcII, we assign these four resonances to the NH protons of His116, His118
and His196 from the Zn1 site and His263 of the Zn2 site. The resonance at 42 ppm is not
solvent-exchangeable and can be assigned to the meta proton of His118, which binds
metal through the δN in BcII. This is consistent with the multiple Co(II) binding sites
identified by EPR, and the observation of both the S6Co(II) CT band and the d6d bands,
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both with one eq of Co(II), indicating that the first eq of Co(II) distributes between the
two metal binding sites.
The NMR spectra of Bla2 are very similar to those previously reported for BcII,
[15] with the notable exception of a resonance assignable to the -CH2 protons of a
Co(II)-coordinated cysteine (spectra were recorded to 400 ppm). One possibility is that
our procedure to prepare the 1H NMR samples resulted in oxidation of Cys221 to the
sulfoxide. Similar oxidation has been suggested for CcrA, [32] and an oxidized Cys221
has been observed in crystal structures of BcII [38] and VIM-2. [39]
Co K-Edge XAS. Comparing the EXAFS of 1Co-Bla2 and CoCo-Bla2 (Figure 6)
shows little quantifiable difference, consistent with the optical, NMR and EPR studies
described above. The major difference is in the height of the main peak, reflective of
either higher coordination number or lower overall disorder in the first shell on addition
of the second eq of Co(II). The shape, particularly the width, of the main feature is
largely unchanged, and curve-fitting results suggest the latter interpretation (lower
disorder) better reflects the apparent difference. Best fits for 1Co- and CoCo-Bla2 are
shown in Figure 6, and summarized in Table 4. Detailed fitting results, including fits to
unfiltered EXAFS, are presented in Supporting Information, Figure S1 and Table S1 for
1Co-Bla2, and Figure S2 and Table S2 for CoCo-Bla2.
The distributed binding indicated above leads to the expectation that both 1Coand CoCo-Bla2 would reflect an average of the Zn1 and Zn2 coordination spheres, with 4
N/O and 0.5 S comprising the first shell. In both cases, inclusion of a partial sulfur
scatterer dramatically improves the quality of the first shell fits. For 1Co-Bla2, the
average first shell bond length is reflective of 4- or 5-coordination (Fit S1-1). While the
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fit residual decreases nearly 3-fold (63 %) when the fit includes a mixed first shell of
nitrogen and oxygen (compare Fits S1-1 and S1-2), the difference in refined distances
(0.15 Å) is at the resolution of the data (0.14 Å). An even greater improvement is seen on
addition of a sulfur scatterer (70 %, compare Fits S1-1 and S1-3). The three shell fit,
including resolved N, O and S shells, results in an overall 83 % improvement from the
single scattering fit (Fit S1-1 vs. S1-4), and 43 % over the N/O + S fit (Fit S1-1 vs. S1-4),
although the refined N and O distances are outside the resolution of the data. For this
reason, multiple scattering fits were conducted using a first shell of 4 N/O + 0.5 S and
indicate an average of 2 His ligands per Co ion (Fit S1-5). Inclusion of a Co-Co vector in
this fit leads to only 8 % improvement in the fit residual, suggesting a bridged bimetallic
cluster is not present (Fit S1-6).
Similar results are obtained for CoCo-Bla2 (Fig. 6, Bottom, and Figure S2 and
Table S2). The average first shell bond length is unchanged from 1Co-Bla2 (compare Fits
S2-1 and S1-1). A mixed first shell of N and O leads to a 49 % improvement in fit
residual with N and O distances at the resolution of the data (Fits S2-1 and S2-2) and
inclusion of a partial sulfur scatterer leads to a 70 % improvement in the fit residual.
Multiple scattering fits, using 4 N/O + 0.5 S to model the first shell, again indicate an
average of 2 His ligands per Co ion. The appearance of the outer shell scattering would
suggest some rearrangement on addition of the second Co(II) ion, but this information is
outside the scope of the current analysis. Inclusion of a Co-Co vector in this fit leads to a
20 % improvement in fit residual, while increasing the number of variable parameters to
14 from 12 (a 17 % increase). The refined Co-Co distance is shorter than the Zn-Zn
separation in similar systems, including this one (below), while it is expected, if present
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to be slightly longer due to the modestly larger size of the Co(II) ion. We take this as
evidence that the aquo bridge is replaced by one solvent on each metal ion in fully loaded
CoCo-Bla2, in accord with our previous studies of CcrA. [32]
Zn K-Edge XAS. In contrast to the distributed binding observed with Co, the
binding of Zn by Bla2 appears to be sequential. The Fourier transformed EXAFS for
1Zn-Bla2 shows much higher outer shell intensity than its ZnZn counterpart, which
shows much better resolution in its outer shell scattering (Figure 7, Top). Qualitatively,
this is consistent with binding of the first equivalent of Zn(II) in the Zn1 site, bearing
three His ligands. Population of the Zn2 site would then be expected to (i) broaden the
first shell with addition of the sulfur ligand, (ii) lower the overall outer shell scattering, as
the average number of His ligands is reduced from 3 to 2 and (iii) sharpen the outer shell
features as the dinuclear site becomes better organized. This description is fully
consistent with the Fourier transforms presented in Figure 6.
The qualitative description presented above is also supported by the curve fitting
results (best fits are shown in Figure 7 and Table 4, detailed results are shown Figure S3
and Table S3 for 1Zn-Bla2, and Figure S4 and Table S4 for ZnZn-Bla2), which show the
Zn in 1Zn-Bla2 is coordinated by 4 N/O donors, including 3 His ligands. Inclusion of a
partial sulfur scatterer does not significantly improve the fit (< 30 %), while resulting in
an unreasonably short Zn-S distance (2.23 Å, compare Fits S3-1 and S3-2). Similarly, a
mixed first shell of N and O donors leads to a minimal improvement in the fit residual,
only slightly larger than simply increasing the number of variable parameters (compare
Fits S3-3 and S3-4 to Fit S3-1), with a separation in Zn-N and Zn-O distances that is less
than the resolution of the data. Multiple scattering fits indicate an average of 3 His
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ligands per Zn, and inclusion of a Zn-Zn vector in this fit results in only 18 %
improvement in fit residual with a relatively short refined Zn-Zn distance of 3.36 Å.
Together, we take this as evidence that there is no population of the Zn2 site in 1Zn-Bla2,
and that there is not sub-populations of di-Zn and apo-Bla2.
In contrast, the coordination sphere of the average Zn(II) in ZnZn-Bla2 clearly
includes 0.5 S donors, as well as 4 N/O. The average first shell bond length (in N/O only
fits) increases by 0.05 Å over 1Zn-Bla2 (compare Fits S4-1 and S3-1), suggesting an
increase in average coordination number and/or the presence of a larger scatterer. A
mixed first shell of resolved Zn-N and Zn-O leads to a 70 % decrease in the fit residual,
though the distances are right at the resolution of the data (Fits S4-1 and S4-2). Inclusion
of 0.5 S with 4 unresolved N/O donors leads to an 88 % improvement in the fit residual
(compare Fits S4-3 and S4-1), and a three-component N + O + S fit results in an overall
93 % reduction in residual. For simplicity, multiple-scattering fits were restricted to a
first shell of 4 N/O + 0.5 S donors. The fits are consistent with the average number of
imidazoles being reduced from 3 to 2 on addition of the second eq of Zn(II). Inclusion of
a Zn-Zn interaction leads to a 43 % improvement in the fit residual, while increasing the
number of variable parameters from 12 to 14. The refined Zn-Zn distance of 3.44 Å is the
same as that seen in other resting state dinuclear MLs by both XAS [40] and diffraction,
[41-43] but very different from the 3.6-3.7 Å EXAFS-derived separation reported earlier
for BcII. [44]
The discrepancy in metal-binding mechanisms followed by Bla2 led us to
examine Zn binding by the B1 ML CcrA from B. fragilis. The metal site in CcrA is
analogous to Bla2 and, in light of our previous work on Co binding by CcrA, [32] we
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expect the same pattern as Zn binding by Bla2 with the first metal ion exclusively
populating the Zn1 site. As can be seen in Figure 8 (Top), the FTs for 1Zn-CcrA and 1ZnBla2 are remarkably similar. The similarity of the FTs is reflected in the curve fitting
results for 1Zn-CcrA (Table S5 and Figure S5), which are nearly identical to 1Zn-Bla2,
including only minimal improvements on (i) addition of a partial sulfur scatterer
(compare Fits S5-2 and S5-1), (ii) using resolved N and O shells (Fits S5-3 and S5-1), or
(iii) inclusion of a Zn-Zn vector in multiple scattering fits (Fits S5-4 and S5-5).
At first glance, the similarity of Zn-loaded CcrA and Bla2 dissolves on loading
the second eq of Zn(II). The main peaks in the EXAFS FTs for ZnZn-CcrA and ZnZnBla2 are strikingly different (Figure 8, Center), although the CcrA FT returns nearly to
baseline at a point similar to Bla2. The overall curve fitting results indicate that the
apparent difference in their FTs is an artifact of subtle differences in structure. The
average first shell bond length increases on addition of a second Zn(II) to CcrA, though
not as much as for Bla2, and the best fit with only N/O scatterers indicates an average
coordination number of 4 (Fit S6-1). Inclusion of a partial sulfur scatterer improves the fit
residual by 48 % (compare Fits S6-2 and S6-1), and this is a well-defined minimum
(compare Fits S6-2 and S6-3). Qualitatively, this leads to a much better match of the
main peak’s amplitude, with a small shoulder that contributes to the first outer shell peak
(Figure S6A), typically ascribed to M-His and/or M-CCO2- scattering. The same fit,
replacing the Zn-S with a Zn-C scattering path gives only a 32 % improvement (Fit S6-5
vs. Fit S6-1), while inclusion of both leads to an overall 66 % decrease in fit residual (Fit
S6-4). The refined Zn-S distance for ZnZn-CcrA is 0.06 Å longer than that obtained for
ZnZn-Bla2. Comparison of the combined Zn-S/Zn-C scattering in k-space for these two
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scenarios (see Figure S7) shows that as the Zn-S and Zn-C distances converge, a partial
cancellation effect leads to the lack of an obvious Zn-S interaction in the ZnZn-CcrA FT.
[45]
Multiple scattering fits for ZnZn-CcrA indicate an average of 2 His ligands per
Zn, and inclusion of a Zn-CCO2- scattering path (increasing the number of variables from
14-16), leads to a modest 17 % improvement in Rf (compare fits S6-6 and S6-7). In both
cases, addition of a Zn-Zn vector leads to $50 % improvement in the fit residual
(compare Fit S6-6 to Fit S6-8, and Fit S6-7 to Fit S6-9). The refined Zn-Zn distance is,
again, fully consistent with those observed for other resting di-Zn MLs by XAS [40]
and diffraction. [41-43]
Stopped-Flow of 1Zn- and 1Co-Bla2. The distributed binding of Co(II) by Bla2,
as demonstrated above, cannot distinguish between potential populations of mono-Co(II)
Bla2 (loaded in either the Zn1 or the Zn2 site) and a mixture of apo- and fully-loaded diCo(II) Bla2. As can be seen in Figure 9, while 1Zn-Bla2 does not stabilize an
intermediate with nitrocefin, 1Co-Bla2 clearly does. The lack of accurate values of Km
and kcat for 1Co-Bla2 preclude the simulation of these data. However, in recent work with
the dinuclear B3 ML L1, we showed that occupation of the Zn1 site was sufficient for
catalysis, but both metal ions were needed to stabilize the nitrocefin-derived intermediate,
[46] as originally described by Wang, et al, with ZnZn-CcrA. [34] Thus, the data in Fig.
9 indicate that there is a significant population of CoCo-Bla2 present at 1 eq Co(II) per
protein, at least under turnover conditions.
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Discussion
Biochemical Characterization. Previously, Palzkill and co-workers reported the
over-expression and purification of recombinant Bla2. [5] In this protocol, the ompA gene
was fused to the gene for Bla2, and this construct was designed to export Bla2 into the
culture growth medium, requiring only cation exchange and Sepharose S-200
chromatographies to obtain 0.4 mg of purified Bla2 per liter of growth culture. To
improve the yield, we modified the published purification protocol, using a Minitan
ultrafiltration system to concentrate the crude protein solution. A similar protocol was
used to purify recombinant CcrA, which is also exported into the growth medium during
over-expression. [37] We then purified Bla2 using a single SP-Sepharose
chromatographic step, yielding 17-23 mg of purified Bla2 per liter of growth medium.
The Zn(II) content of as-isolated Bla2, prepared in this way, was 1.0 + 0.2 eq per
protein, substantially lower than that reported for as-isolated BcII (1.4 – 1.8 eq) [15, 47]
and CcrA (1.5 – 2.0). [32, 37, 48, 49] Addition of excess Zn(II) to the as-isolated
enzyme, followed by extensive dialysis against metal-free buffer results in an enzyme
that binds 1.4 + 0.1 eq of Zn(II). In similar studies, BcII has been reported to tightly bind
2.0 + 0.1 equivalents of Zn(II). [50] Given the two enzymes share 89 % sequence identity
and 92 % sequence homology, [5] it is not clear why the metal contents of BcII and Bla2
are so different. A possible source of this discrepancy may lie in quantification of the
enzymes. As determined by amino acid analyses, the extinction coefficient of Bla2 at 280
nm is 25,400 M-1cm-1, while that of BcII is 30,500 M-1cm-1, [50] a difference of 17 %.
Using the smaller extinction coefficient of Bla2, a metal stoichiometry of 2.0 Zn(II)
tightly bound to BcII would be reduced to ~ 1.7 eq. Alternately, using the larger
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extinction coefficient of BcII, the metal stoichiometry of as isolated Bla2 would be
reduced to ~ 0.8 eq Zn(II) per protein. This is inconsistent with the steady state kinetics,
which would have been expected to show an increase in kcat on further addition of Zn(II).
Again, given the similarity in their amino acid sequences, it is unclear why the two
enzymes have extinction coefficients, and metal contents, that vary so greatly.
Steady-state kinetic studies on as-isolated Bla2 containing 1 equivalent of Zn(II),
using several different substrates, show that the as-isolated enzyme is catalytically-active
(Table 1). Previously, Palzkill, et al, reported that recombinant Bla2 (Zn(II) content
unknown) exhibited a Km of 75 + 5 M and a kcat 313 + 21 s-1, when using nitrocefin as
substrate. [5] In our hands, recombinant Bla2 containing 1 eq of Zn(II) exhibited a Km of
25 + 4 M and a kcat of 41 + 3 s-1 with nitrocefin as substrate. These values compare
favorably with previous steady-state kinetic data on BcII, which exhibits a Km of 9 μM
and a kcat of 43 s-1 with nitrocefin. [47] The stark difference in steady-state kinetic
behavior of the two recombinant Bla2 preparations may be due to differing metal content
and/or different assay conditions. Our assays were conducted at 25 C, while the
preceding studies were conducted at 30 C, [5] although this should result in only a 1.25fold difference in kcat.
Our initial efforts to use the identical conditions (50 mM Hepes, pH 7.5, 50 μM
Zn(II) and 20 μg of bovine serum albumin (BSA)) gave irreproducible results, which we
attribute to enzyme instability under these conditions. The predicted pI of Bla2 is 7.6;
therefore at pH 7.5, the enzyme would be expected to be predominantly zwitterionic and
insoluble. We therefore lowered the pH of our assay buffer to 6.5, and the kinetic assays
were much more reproducible. At present we cannot rule out any differences in the
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enzymes that may have been introduced in the modified purification protocol. Clearly,
the enzymes are different, as Palzkill, et al, reported that their recombinant Bla2 does not
hydrolyze imipenem, [5] while our recombinant Bla2 exhibits a Km of 89 M and a kcat of
92 s-1 when using imipenem as substrate (Table 1). However, at present, the source of
these differences is unclear.
Metal Binding. Steady-state kinetic studies revealed that Bla2 containing 1
equivalent of Co(II) is less than ½ as catalytically active as CoCo-Bla2 (Table 2),
suggesting that (i) Co(II) binding to Bla2 is random and that both metal ions bind with
similar KD values or (ii) that Bla2 exhibits positive cooperative binding of Co(II). A
distributed binding model is supported by optical studies, which show both the d-d bands
(Zn1) and the Scys6Co(II) LMCT (Zn2), even at a loading of only 0.5 eq of Co(II), whose
intensity maximizes above 2 eq of Co(II) per protein (Fig. 3). The EPR spectra of 1Coand CoCo-Bla2 are nearly superimposable, and suggest 5- or 6-coordination for both,
with at least one solvent ligand (Fig. 4). The 1H NMR spectra of 1Co- and CoCo-Bla2 are
nearly identical, showing the same five paramagnetically-shifted resonances (Fig. S8).
Four of these resonances are solvent exchangeable (Fig. 5), indicating a total of four
coordinated histidines with only 1 eq of Co(II) added. The Co K-edge EXAFS are also
consistent with a distributed binding model, with only an apparent decrease in disorder
accompanying addition of the second eq of Co(II). In sum, the spectroscopic studies of
Co(II)-binding by Bla2 overwhelmingly indicate distributed binding of Co(II) by Bla2,
but cannot distinguish between random and cooperative mechanisms in the resting
enzyme.
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In contrast to Co(II), the binding of Zn(II) by Bla2 appears to be sequential.
EXAFS of 1Zn-Bla2 show the first eq of Zn(II) clearly binds to the Zn1 site. Addition of
a 2nd eq of Zn(II) to form ZnZn-Bla2 leads to the observation of a Zn-S interaction,
consistent with Cys221 coordination (and metal bound at the Zn2 site), and a clear Zn-Zn
interaction at ~ 3.4 Å. The EXAFS are consistent with the steady-state kinetics, which
showed that ZnZn-Bla2 is not twice as active as 1Zn-Bla2, suggesting that the second
Zn(II) ion does not greatly affect catalysis and that the first site of Zn(II) binding, Zn1 in
this case, is more important kinetically. [15, 44, 51] To our knowledge this is the first
documented example of a naturally occurring Zn enzyme that follows distinct metal
binding pathways, dependent on whether the metal is Zn(II) or Co(II), and strongly
underscores the need to demonstrate transferability when studying Co(II)-substituted
Zn(II) enzymes.
The stopped-flow kinetics studies are consistent with the difference in metal
binding mechanisms, and they offer the only information regarding the two possibilities
for Co(II)-binding (random or cooperative). 1Zn-Bla2 does not stabilize the nitrocefinderived reaction intermediate. The lack of an intermediate suggests that the situation
described for resting 1Zn-Bla2 by EXAFS, a homogeneous population of mono-Zn
enzyme, with Zn(II) bound in the canonical Zn1 site, is preserved during turnover. In
contrast, the appearance of an intermediate is clear in 1Co-Bla2 catalyzed nitrocefin
hydrolysis. Within the accuracy of 665 for the intermediate, the limiting concentration of
the Co-bound intermediate (ca. 12 M) suggests that, under turnover conditions, 1CoBla2 may, in fact, contain nearly equal populations of apo- and CoCo-Bla2, though at the
current level of the data we can only speculate.
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Comparison with CcrA. The metal-binding properties of two other B1 MLs have
been studied in detail. A set of enzymological, optical, X-ray absorption and magnetic
resonance studies of Co(II) binding, similar to those presented here, by the B1 ML CcrA
indicated sequential binding, with the first equivalent of Co(II) bound exclusively at the
Zn1 site. To reach that conclusion, the combined spectroscopic approach was essential.
For example, the EPR spectra of 1Co-CcrA and CoCo-CcrA were distinct but not
definitive, both signals suggestive of 5/6-coordination. The XAS also indicated 5/6coordination, higher, on average, than the corresponding Zn (vide infra). Neither XAS
nor EPR showed evidence of a covalent bridge between the Co ions.
The EPR studies presented here also suggest 5/6-coordination for both Co(II) ions
in Bla2, with little or no evidence of a bridging interaction. However, the XAS-derived
average first shell bond lengths for 1Co- and 1Zn-Bla2 differ by only 0.02 Å, while those
of 1Co- [32] and 1Zn-CcrA differ by 0.12 Å. A similar trend is apparent comparing the
di-Co and di-Zn enzymes. The average first shell bond lengths for CoCo- and ZnZn-Bla2
differ by only 0.01 Å, while those of CoCo- [32] and ZnZn-CcrA differ by 0.12 Å. These
data clearly indicate that Co(II)-substitution better preserves the coordination number of
the native Zn(II) in Bla2 than it does in CcrA, which clearly indicates an increase in
coordination number for both metal ions.
For Co(II)-substituted CcrA, the S6Co charge transfer band was difficult to
assess, at any metal/protein ratio, and the XAS showed no statistically significant Co-S
scattering. Ultimately, it was observation of the -CH2 protons of Cys221 by NMR (at
208 ppm), only in CoCo-CcrA, that offered a clear indication that the Zn2 site is not
populated until the Zn1 site is filled. Unlike CcrA, the S6Co LMCT band was easily
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detected for Bla2, at all metal/protein ratios, and the Co-S scattering was prominent at
both 1 and 2 eq of Co(II). In this case we failed to detect the -CH2 resonance by NMR.
We also note that the EXAFS-derived Zn-S distance is 0.06 Å longer in CcrA than in
Bla2, which may indicate that Cys221 is a weaker donor in CcrA. This unexpected
correlation is the subject of continuing investigation.
Comparison with BcII. The B1 ML BcII is the most extensively studied of all
MLs. The initial crystal structure of BcII showed a mononuclear enzyme, with Zn(II)
binding in the consensus Zn1 site. [52] Subsequent structures showed that BcII contains a
dinuclear Zn(II) binding site. [15, 53] The conflicting crystallographic data suggested the
Zn(II) binding affinities at the Zn1 (3H) and Zn2 (DCH) sites in BcII might be different.
Subsequently, di-Co(II) and mixed-metal (ZnCo) derivatives were reported and
characterized spectroscopically, establishing a clear hierarchy of metal affinities at pH
6.0 that was less pronounced at physiological pH. [54] Both sites have been shown to be
important for efficient -lactam hydrolysis. [18, 55] More recent studies have shown that
BcII shows a very modest preference for binding Co(II) at the Zn1 site, but evidence of a
di-Co(II) population is apparent at very low (~ 0.6 eq) Co(II) stoichiometries. [15] The
present studies on Bla2 are not inconsistent with this model, though they offer no direct
evidence as to the speciation of resting 1Co-Bla2.
Freeze quench spectroscopic studies of di-Co(II) BcII show a direct interaction of
the substrate with both metal ions during catalysis, and indicate the presence of a
covalent bridge in the resting enzyme, based on the observation of a parallel mode EPR
signal. [56] The presence of the bridge appears, at present, unique to di-Co BcII, as in
both CcrA and Bla2, we see no concrete evidence for Co-Co interactions in the Co K-
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edge XAS or significant magnetic coupling in their EPR. [32] NMR studies of BcII also
show that the -CH2 resonance shifts slightly downfield with increasing Co(II) loading,
consistent with a small amount of magnetic coupling between the two metal ions. [15]
While the -CH2 resonance was not observed for Bla2, no effects of Co(II) stoichiometry
are apparent in the NMR spectra.
Significantly less data is available with respect to Zn(II) binding. The distributed
binding of Co(II) by BcII is consistent with an earlier EXAFS study of Zn(II)-binding by
the same enzyme. [44] Using optical competition and fluorescence spectroscopy, de
Seny, et al showed that BcII exhibits negative cooperative Zn(II) binding and indicated
that there are not high and low affinity Zn(II) binding sites. [44] They further contended
that the first equivalent of Zn(II) distributes between the two sites and hinted that the
binding of substrate may lead to Zn(II) preferentially binding the Zn2 site in the active
enzyme, [44] consistent with recent studies on BcII using substoichiometric Co(II). [57]
In contrast, both CcrA and Bla2 have been shown here to bind Zn(II) sequentially. To the
greater issue of Co(II)-substitution, it appears at present that the substitution is
completely faithful in BcII; it reproduces the order of addition in CcrA, but not
coordination number, without the formation of a bridged cluster; and it fails for Bla2
where distinct metal-dependent mechanisms are observed.
It has been recently shown that the more active mono-Co(II) form of BcII binds
metal at the Zn2 site. [57] The present studies on Bla2 are not inconsistent with this
picture, although the rapid kinetics of 1Co-Bla2 with nitrocefin (Fig. 9) appear more
consistent with a cooperative binding model for Co(II), at least in the presence of
substrate. Page and coworkers have argued, using pH-dependent kinetics of Co(II)-
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substituted BcII, that Co(II)-binding is cooperative in the presence of substrate, and that
the dinuclear Co(II)-containing analog is the only catalytically-active form of the
enzyme. [16, 58] The present studies on 1Co-Bla2, particularly the rapid kinetics in Fig.
9, lend some support for this model. More recent work suggests that a similar mechanism
is operative in Zn(II)-BcII. [59] In contrast, Vila, [57] de Seny, [44] and Wommer [60]
report that both the mono- and dinuclear Zn(II)-containing analogs of BcII are
catalytically-active. Clearly, mono-Zn(II) Bla2 is active, and it shows no evidence of
cooperativity. The related B1 ML CcrA has been shown to be active as a both a monoZn(II) [61] and a mono-Co(II) enzyme, [37] and the B3 lactamases L1 [40] and GOB
[12] have also been shown to be active as mono-Zn enzymes.
Analysis of the kinetic data demonstrates that 1Zn-Bla2 utilizes a rapidequilibrium mechanism to hydrolyze nitrocefin, and the rate constants suggest that lactam C-N bond cleavage is rate-limiting. Vila and coworkers proposed the same ratelimiting step for BcII. [35] Previous studies on L1 and CcrA have shown that these
enzymes utilize a similar rapid-equilibrium mechanism to hydrolyze nitrocefin, and a
different mechanism to hydrolyze other substrates. [21, 62] Stopped-flow studies of 1ZnBla2 show that it behaves similarly, utilizing a distinct one-step mechanism in the
hydrolysis of imipenem and cefaclor, without evidence of intermediate formation. Further
conclusions cannot be reached without the availability of similar studies on ZnZn-Bla2.

Summary

Taken together, our data demonstrate that 1Zn-Bla2 is catalytically-active and
EXAFS data on this analog demonstrate that Zn(II) binds in the consensus Zn1 site. The
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EXAFS data also show that Zn(II) binding is sequential, as in CcrA [32] and L1. [40] In
contrast, all of the spectroscopic and kinetic data on Co(II)-containing Bla2 strongly
indicate that Co(II) binding is either random or positive cooperative. A summary scheme
showing how Zn(II) and Co(II) bind to Bla2 is shown in Figure 10. Further studies are
required to address why Zn(II) and Co(II) behave differently in Bla2, and X-ray crystal
structures of both analogs may yield information about the different metal binding
properties. In particular, a crystal structure of Bla2 may shed light on why this enzyme
appears to have different biochemical properties than BcII, in spite of the near identity of
the two enzymes’ primary structures. We believe this is the first documented example of
a Zn enzyme binds Co(II) and Zn(II) via distinct mechanisms, underscoring the
importance of validating transferability when extrapolating results on Co(II)-substituted
proteins to the native Zn(II)-containing forms.
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Table 1: Steady-state kinetic parametersa for nitrocefin, imipenem, cefaclor, and

meropenem hydrolysis by Bla2 containing 1 equivalent of Zn(II).

Km (M)
kcat (s-1)
a

Substrate:
Nitrocefin
25 + 4
41 + 3

Substrate:
Imipenem
89 + 35
92 + 21

Substrate:
Cefaclor
67 + 6
24 + 1

Substrate:
Meropenem
110 + 42
49 + 11

Kinetic assays were conducted at 25 ◦C in 50 mM Hepes, pH 6.5.

Table 2: Steady-state kinetic parameters for Bla2 containing 1 or 2 equivalents of Zn(II)

or Co(II).
1Co(II)-Bla2

2Co(II)-Bla2

1Zn(II)-Bla2

2Zn(II)-Bla2

18 + 2
19 + 1

30 + 9
47 + 5

28 + 4
32 + 2

35 + 4
42 + 2

Km(μM)
kcat (s-1)

All experiments were conducted at 25 ◦C in 50 mM Hepes, pH 6.5. The Bla2 analogs were prepared by
adding the indicated equivalents of metal to apo-Bla2 before the assays were conducted.

Table 3:

Kinetic constants used in KINSIM simulations, using the mechanism in

Scheme 1.a
constant

value used in simulation value used in simulation value used in simulation
for nitrocefin
for imipenem
for cefaclor
K1
0.12 ± 0.01
0.13 ± 0.01
2.2 + 0.1
k2
10 ± 1
35 ± 1
15 ± 1
k-2
4±1
Set to 0
Set to 0
k3
40 ± 1
k-3
Set to 0
a
ProK software (nonlinear Marquardt-Levenberg algorithm) was used to determine the error in the rate
constants.
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Table 4. Best fits to Co- and Zn-Bla2 and Zn-CcrA EXAFS. a

Fit
S1-5

Sample & Model

M-N/O

M-S

2.03 (6.9)

2.27 (1.8)

1Co-Bla2

4.01 (5.8) 4.21 (13)

CoCo-Bla2

2.91 (3.6) 3.29 (18)
2.05 (3.6)

2.27 (3.5)
3.85 (10)

4 N/O (2 His) + 0.5 S

S3-5

M-M

2.91 (4.6) 3.26 (11)

4 N/O (2 His) + 0.5 S

S2-5

M-His b

1Zn-Bla2

4.17 (17)

2.91 (6.6) 3.16 (9.8)
2.03 (6.6)
4.11 (19)

4 N/O (3 His)

S4-6

4.42 (23)

ZnZn-Bla2
2.90 (7.1) 3.08 (5.8)
4 N/O (2 His) + 0.5 S

2.04 (6.3)

2.27 (2.6)

3.44 (15)
4.08 (18)

4.43 (25)

+ Zn-Zn

S5-4

1Zn-CcrA

2.91 (6.6) 3.16 (9.8)
2.03 (6.9)
4.11 (19) 4.42 (23)

4 N/O (3 His)

S6-9

ZnZn-CcrA
2.91 (6.8) 3.15 (3.5)
4 N/O (2 His) + 0.5 S

2.03 (5.9)

2.33 (4.5)

3.44 (11)
4.17 (22) 4.42 (18)

+ Zn-Zn c
a

Distances (Å) and disorder parameters (in parentheses, 2 (10-3 Å2)) shown derive from integer or halfinteger coordination number fits to filtered EXAFS data. For detailed fitting results, including ranges in
both k- and R-space, fit residuals and fits to unfiltered data, see Figures S1-S6 and Tables S1-S6 in
Supporting Information.

b

Multiple scattering paths represent combined paths, as described previously (see Materials and Methods).

c

This fit includes a Zn-C scattering path (0.5 C/Zn) at a distance of 2.49 Å (2 = 1.4 x 10-3 Å2).
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Scheme 1
K1

k2

E+S

k3

ES

EX
k-2

Scheme 2
K1

E+S

k2

ES

E+P
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E+P

Figure 1. SDS-PAGE gel of purification of recombinant Bla2. Lane 1: molecular weight

markers (from top to bottom: 150 kDa, 100 kDa, 75 kDa, 50 kDa, 35 kDa, 25 kDa, and
15 kDa); lane 2: boiled cell fraction of cells before induction with IPTG; lane 3: soluble
fraction after French pressing and dialysis against 50 mM Hepes, pH 6.5; Lane 4: purified
Bla2 after SP-Sepharose chromatography.
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B

A

C

Figure 2. Progress curves for the reaction of 1Zn-Bla2 with nitrocefin (A), imipenem (B) and cefaclor (C).
(A) The concentration of product increased over time using 25 (□) and 50 (○) M nitrocefin, while
substrate concentrations decreased over time using 25 (◊) and 50 (Δ) M nitrocefin. The solid progress
curves were generated by KINSIM, using the mechanism in Scheme 1 and the kinetic constants in Table 3.
(B) Progress curves of the reaction of imipenem and Bla2 containing 1 eq. Zn(II) at 4 oC. The
concentrations of substrate were (Δ) 50 M, (□) 25 M, and (○) 10 M, and the concentration of Bla2 was
20 M. The solid lines were generated by using KINSIM, the mechanism in Scheme 2, and the kinetic
constants in Table 3. (C) Progress curves of the reaction of cefaclor and Bla2 containing 1 eq. Zn(II) at 4
o

C. The concentrations of substrate were (Δ) 50 M, (□) 25 M, and (○) 10 M, and the concentration of

Bla2 was 20 M. The solid lines were generated by using KINSIM, the mechanism in Scheme 2, and the
kinetic constants in Table 3.
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Figure 3. Optical titration of apo-Bla2 with Co(II). The concentration of apo-Bla2 was

1.2 mM apo-Bla2, and the buffer was 15 mM Hepes, pH 6.5, containing 100 mM NaCl.
The enzyme was titrated with 0.5, 1.0, and 2.0 equivalents of Co(II) (bottom to top at 550
nm). Inset: Absorbance changes as the equivalents of Co(II) increase.
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Figure 4. EPR spectra from Co(II)-containing Bla2. (A) 1Co-Bla2, 2 mW, 11 K; (B) CoCo-Bla2, 2 mW,
11 K; (C, solid line) = (B) – (A); (C, dashed line) 1Co-Bla2, 2 mW, 11 K; (D, solid line) CoCo-Bla2  0.5,
50 mW, 7 K; (D, dashed line) 1Co-Bla2, 50 mW, 7 K; (E, solid line) CoCo-Bla2  0.5, 100 mW, 7 K, rapid
passage; (E, dashed line) 1Co-Bla2, 100 mW, 7 K, rapid passage; (F, solid line) derivative of rapid passage
spectrum of CoCo-Bla2; (F, dashed line) 1Co-Bla2, 2 mW, 11 K. Rapid passage spectra were recorded
using second-derivative quadrature phase-sensitive detection. The intensities of spectra shown in A – C are
correct relative to each other. Intensities of pairs of spectra in D – F are arbitrary, but within each pair the
intensities are correct when the multiplication factors given are taken into account.
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Figure 5. 500 MHz 1H NMR spectra of CoCo-Bla2 in 10% D2O and 90% D2O.
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Figure 6. Fourier transformed EXAFS spectra of Co(II)-substituted Bla2. (Top) Direct

comparison of 1Co- (gray line) and CoCo-Bla2 (black line). (Center) Best fit (open
symbols) for 1Co-Bla2. (Bottom) Best fit (open symbols) for CoCo-Bla2. See Table 4
and Supporting Information for fit details.

92

Figure 7. Fourier transformed EXAFS spectra of Zn(II)-Bla2. (Top) Direct comparison

of 1Zn- (gray line) and ZnZn-Bla2 (black line). (Center) Best fit (open symbols) for 1ZnBla2. (Bottom) Best fit (open symbols) for ZnZn-Bla2. See Table 4 and Supporting
Information for fit details.
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Figure 8. EXAFS Fourier transforms for Zn-CcrA. (Top) Direct comparison of 1Zn-

CcrA (black line) and 1Zn-Bla2 (gray line). (Center) Direct comparison of ZnZn-CcrA
(black line) and ZnZn-Bla2 (gray line). (Bottom) Direct comparison of 1Zn-CcrA (thin
black line) and ZnZn-CcrA (thick black line).
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Figure 9: Stopped-flow kinetic traces for the hydrolysis of nitrocefin by 1Co- and 1Zn-

Bla2, monitored at 665 nm.
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Figure 10: The proposed active site of Bla2 after the addition of 1 or 2 equivalents of

Zn(II) (left) or Co(II) (right) to apo-Bla2.
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Figure S3. Fourier transforms (A) of k3-weighted EXAFS (B) for 1Co-Bla2 (solid
lines),and corresponding curve fits (open symbols) from Table S1, numbers correspond
to entries in the associated Table.
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Chapter IV

Metal Titration of BcII from Bacillus cereus

Introduction

There has been much controversy over the metal binding behavior of B1 metallo-lactamases. As previously noted, CcrA binds metals sequentially, populating the Zn1

site completely before populating the Zn2 site. Bla2 metal binding behavior varies
depending on the metal. Zinc binds in the same manner as CcrA, while cobalt shows no
preference for either site populating both sites regardless of stoichiometry.

Recent

spectroscopic evidence suggests the binding behavior of BcII from Bacillus cereus
displays minimal preference for either site and may display cooperativity. [1]
Early studies of metal binding using competition titration shows a greater
disparity of the metal binding affinities with a first dissociation constant of 0.62 nM and a
second dissociation affinity of 1.50 M. [2] A difference of three orders of magnitude
between the two sites would fully populate the first site before occupying the other. The
first crystal structure collected on BcII contained a single equivalent of zinc located in the
Zn1 (3H) site. [3] This evidence suggested that the binding is indeed sequential. Later
studies have shown different results. Cobalt metal substitution data has shown that the
metal incorporation is not sequential. [1] Substoichiometric additions of cobalt display
UV-visible spectra corresponding to the Zn1 (3H) site at the same time that it displays a
LMCT band corresponding to a cobalt-sulfur bond formation. An EPR titration of apoBcII with cobalt displays the presence of four species. The primary species maximized at
0.8 equivalents and was described as axial. The secondary species maximized at 2.0
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equivalents and was described as rhombic. The other two sites correspond to
nonspecifically bound and solvent bound cobalt. There is also an observed discrepancy
between the EPR detected cobalt equivalents and the quantity of cobalt added, which is
attributed to an increase in the quantity of spin coupled cobalt (II) present in the bridged
dicobalt species. [4]
The metal binding to BcII has been studied with mass spectrometry, which shows
that the mass corresponding to dizinc BcII grows consistently from zero to two
equivalents as the population of apo BcII steadily decreases and the population of
monozinc BcII grows to a small population (20%) before disappearing. [5] A kinetic
analysis of the zinc and cobalt substituted enzymes have suggested similar results. [6, 7]
These studies show cooperativity in the binding and a loss of metal ion during the
hydrolysis of substrate. The enzyme would then require the addition of a metal from the
surroundings to regenerate the active site.
Studying the metal binding behavior of BcII will help to elucidate the active form
of BcII. Reports of the active form of this enzyme vary as much as the metal binding
behavior. The active form of the enzyme is necessary to pinpoint in order to understand
the reaction mechanism and to facilitate rational inhibitor design. There have been reports
that each of the possible forms of the enzyme is the active form. The mononuclear Zn
form present in the initial crystal structures suggested that the Zn1 site is the active form.
[3] A recent study of mutations within the Zn2 site demonstrates a reduction of rate if
metal binding is disrupted. [1] Another study suggest that the enzyme’s physiological
state is apo, but the binding of substrate induces a conformational change that results in
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the binding of necessary metal from the surroundings. [8] The dinuclear form of the
enzyme is suggested in more recent studies as the active form of the enzyme. [5]
In summary, the picture of metal binding to BcII has evolved over time and a
clear picture has yet to emerge. This study will use x-ray absorption spectroscopy to look
at the BcII active site as both zinc and cobalt are added to the site.

Experimental Procedures

BcII containing one half, one, and two equivalents of Zn (II) and Co (II) was
perpared and characterized according to published procedures by our collaborators.
Samples for EXAFS (0.5-2 mM) were prepared as previously described. Data collection
and analysis were performed as described in preceding chapters.

Results

Previous spectroscopic experiments of BcII suggests that both the Zn1 and Zn2
sites become populated simultaneously with as little as 0.3 equivalents of metal. With 0.5
equivalents of Co (II), the fewest equivalents available for this study, the best fits to the
EXAFS data are in agreement with this observation. The fits show a mixture of both the
Zn1 and Zn2 sites including four nitrogen atoms, half of a sulfur atom, and two histidines,
which is the average coordination sphere of the two sites. The fit residual improves by
30% with the addition of a Co-Co interaction at 3.56 Å. (Figure 4-2) This distance is
similar to the reported values of other di-cobalt enzymes and ~0.1 Å longer than the 3.4
Å expected from the di-zinc enzyme (based on crystal structures). The one equivalent
form of cobalt-substituted BcII is best fit by the same structural model as the one half
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equivalent form. (Figure 4-3) The bond distances, peak height, and disorder terms are
virtually identical between the two fits. However, the fit residual improves by 50% upon
addition of a Co-Co distance of 3.56 Å. The two equivalent form of cobalt-substituted
BcII has a distinct appearance from the other two samples. (Figure 4-4) The intensity
corresponding to the shell of atoms directly bound to the cobalt increases by
approximately 50%, which corresponds to a decrease in the disorder terms in the nitrogen
and sulfur shells. There is also a lengthening of two of the histidine secondary scattering
pathways. Addition of a Co-Co distance of 3.56 Å improves the fit by 30%.
The zinc-substituted BcII shows similar trends to the cobalt-substituted form.
With one half of an equivalent of zinc (II), both the Zn1 and Zn2 sites appear to be
populated. The best fits include 4 nitrogen atoms and 0.5 sulfur atoms with two histidine
residues. There is a 25% improvement of the fit residual on addition of a Zn-Zn distance
of 3.4 Å. (Figure 4-5) Moving to one equivalent of zinc (II), the best fit remains a mixture
of Zn1 and Zn2, with the addition of a Zn-Zn interaction improving the fit by nearly 30%.
(Figure 4-6) With the ZnZn form of BcII, the best fit uses the same structural model, but
the addition of a Zn-Zn interaction improves the fit by 45%. (Figure 4-7) With increasing
equivalents of metal ions, the disorder terms decrease, which suggests that the sites
become more ordered.

Discussion

The BcII metal titration performed allows us to monitor metal binding behavior at
substoichiometric metal concentrations. BcII appears to show cooperativity in binding of
metal. With even a modest addition of metal, metal fills both sites in the active site.
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Additionally, the improvement of fit upon the addition of a metal-metal interaction
suggests that the site is well ordered and contains a bridge between the metals. The
lowering of the disorder terms with higher equivalents of metal suggests that there may
be small portions of the sample that exists in the monozinc form, but the fraction is
reduced as the sample becomes saturated and moves to a single stable species.
The metal titration of BcII analyzed by EXAFS shows metal binding behavior
unlike the previously studied members of subclass B1. Combined with the analysis of
metal binding in Bla2 [9] and CcrA, [9, 10] subclass B1 displays three unique modes of
binding metal. With the members of the subclass having the same coordinating residues,
these differences in binding modes must be attributed to more subtle interactions such as
hydrogen bonding networks, orientation and arrangement of coordinating residues,
backbone flexibility, and the local environment of the active site.
The metal binding behavior of the B1 metallo--lactamase, CcrA has been well
characterized by optical, magnetic resonance, and X-ray absorption studies. These studies
show sequential binding with both zinc and cobalt. Similar to the monozinc crystal
structure of BcII, the initial equivalents of metal bind to the Zn1 (3H) site, which suggests
that the binding affinity of the Zn1 (3H) site in CcrA is higher than the Zn1 (DCH) site.
This suggests that either the sites have similar binding affinity or upon addition of the
first equivalent of metal the binding site affinity of the second site becomes greater,
encouraging the formation of the dimetal form. The X-ray absorption evidence of a
metal-metal bridge formed with modest additions of metal argues for the latter option.
The sequence homology between the two enzymes is only modest (32%) but both retain
the HXHXD motif that is present in all metallo--lactamase as well as stretches of
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conserved animo acids and thirteen conserved glycines. The variations in primary
sequence allows for the metal binding behavior to be tuned differently, while still
maintaining the stable metallo--lactamase fold.
Comparing BcII metal-binding behavior to Bla2 provides a much more
compelling comparison. The two sequences are nearly identical (92% homology) with
only three changes in the active site pocket, but the metal binding behavior is vastly
different. [1, 10, 11] Bla2 shows different binding behavior depending on the metal ion
presented to it, whereas BcII binds both Zn (II) and Co (II) the same way. There are three
different amino acids present in the secondary shell of the active site, which could
contribute to the change in metal binding behavior. The first difference occurs at position
39, where an isoleucine is replaced with to a valine. Such a modification is relatively
minor, as both groups have the same charge and polarity. The only difference is the
shortening of an aliphatic chain by a single carbon. This change should do little to affect
the overall protein structure, but the aliphatic sidechain is only 4.1 Å away from histidine
210. The variation of the distance of the carbon chain from the binding residue may
indirectly influence the binding affinity. The second alteration between the two sites is
the replacement of glycine 151 with a glutamate. This introduces a large, bulky, charged
group in the place of a hydrogen atom. On the surface of the protein, this disruption will
be far less important than if a residue was imbedded in the internal structure, with the
charge interacting with solvent molecules instead of the hydrophobic core. However, the
this residue is two amino acids away from a histidine residue in the Zn1 (3H) site. The
increased flexibility of the glycine residue and the side chain could modify the backbone
alignment enough to attenuate the metal binding behavior. The final difference is at
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position 182 with modification of a threonine to an alanine. This residue is on the edge of
the active site pocket and introduces a hydrogen bonding residue, which can modify the
existing water network in the active site. With two waters involved in coordinating the
metal centers, the modification of the hydrogen bonding network could provide the
observed metal binding attenuation. With three mutations responsible for different metalbinding behavior, it may be possible with site-directed mutagenesis further probe the
source of these differences.
Comparison to two other members of the B1 subclass shows three distinct binding
modes. BcII displays cooperativity and adopts the ZnZn or CoCo form at
substoiciometric metal content. CcrA shows sequential binding with both zinc (II) and
cobalt (II). It fills the Zn1 site completely before adding metal to the Zn2 site. Bla2
behaves as CcrA when the metal added is zinc (II), but behaves as BcII when the metal
added is cobalt (II). With this wide variety of binding behaviors, it is important to note
that the binding coordination sphere is identical in all of these cases, and secondary
interactions in the active site are a likely cause of the binding differences.

Summary
The metal binding behavior of metallo--lactamase, BcII was studied with x-ray
absorption spectroscopy. These studies show that metal binding to the enzyme occur
concurrently at the Zn1 and Zn2 sites in the active site in substoichiometric quantities of
metal. The EXAFS fits improve upon addition of a metal-metal distance in all samples
studied, which suggests that the metal binding to BcII displays positive cooperativity for
both zinc and cobalt. These studies further support other studies showing the positive
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cooperativity in the metal binding of BcII. The metal binding behavior of BcII differs
from the other members of the B1 subclass studied by x-ray absorption spectroscopy.
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Figure 4-1: Comparison Plot of BcII Titration. Zinc titration (left) and
Cobalt titration (right) with 0.5 equivalents (grey), 1.0 equivalent (black),
and 2.0 equivalents (red) of metal
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Figure 4-2. Fourier transforms (A) of k3-weighted EXAFS (B) for 0.5Co-BcII (solid

lines), and corresponding curve fits (open symbols) from Table 4-1.
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Table 4-1. Detailed EXAFS curve fitting results for 0.5Co-BcII.a
Fit

Model

Co-N/O

Co-S

S1-1

4.5 N/O

2.10 (7.4)

S1-2

4 N/O + 0.5 S

2.02 (8.5)

2.28 (0.8)

2.02 (8.4)

2.27 (0.9)

d

Rf c

Ru c

152

384

32

255

125

180

76

134

4.08 (6.4), 4.25 (9.5)

4 N/O (2His) + 0.5 S
S1-4
a

Co-Co

2.89 (4.2), 3.31 (20)

4 N/O (2His) + 0.5 S
S1-3

Co-His b

2.03 (6.9)

+ Co-Co d

2.94 (2.2), 3.25 (14)

3.56

4.00 (10), 4.28 (16)

(8.8)

2.28 (1.7)

Distances (Å) and disorder parameters (in parentheses, 2 (10-3 Å2)) shown derive from integer or halfinteger coordination number fits to filtered EXAFS data [k = 1.5-12.5 Å-1; R = 0.7-2.3 Å (fits 1-2) or 0.24.2 Å (fits 3-4)].

b

Multiple scattering paths represent combined paths, as described previously (see Materials and Methods).

c

Goodness of fit (Rf for fits to filtered data; Ru for fits to unfiltered data) defined as




, where N is the number of data points.
 Re(  )  Im( ) 

 Re(  i calc ) 2  Im( icalc )2
N

1000*

i 1
N

i 1

d

iobs

2

iobs

2

Inclusion of a Co-C scattering path (0.5 C/Co), along with the parameters of this fit, led to a refined Co-C
distance of 2.50 Å (2 = 0.3 x 10-3 Å2), with a modest decrease in fit residual to Rf = 113.

e

Inclusion of a Co-C scattering path (0.5 C/Co), along with the parameters of this fit, led to a refined Co-C
distance of 2.52 Å (2 = 0.6 x 10-3 Å2), with a modest decrease in fit residual to Rf = 55.
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Figure 4-3. Fourier transforms (A) of k3-weighted EXAFS (B) for 1Co-BcII (solid lines),

and corresponding curve fits (open symbols) from Table 4-2.
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Table 4-2. Detailed EXAFS curve fitting results for 1Co-BcII.a
Fit

Model

Co-N/O

Co-S

S2-1

4.5 N/O

2.11 (7.4)

S2-2

4 N/O + 0.5 S

2.05 (8.7)

2.28 (4.8)

S2-3

4 N/O (2His) + 0.5 S d

2.04 (9.7)

2.27 (5.0)

Co-His b

Co-Co

Rf c

Ru c

124

384

47

355

111

235

63

177

2.95 (2.0), 3.27 (20)
4.02 (23), 4.28 (13)

4 N/O (2His) + 0.5 S
S2-4
a

2.03 (6.9)

+ Co-Co d

2.94 (2.2), 3.25 (14)

3.55

4.00 (10), 4.28 (16)

(6.0)

2.27 (3.7)

Distances (Å) and disorder parameters (in parentheses, 2 (10-3 Å2)) shown derive from integer or halfinteger coordination number fits to filtered EXAFS data [k = 1.5-12.5 Å-1; R = 0.7-2.3 Å (fits 1-2) or 0.24.2 Å (fits 3-4)].

b

Multiple scattering paths represent combined paths, as described previously (see Materials and Methods).

c

Goodness of fit (Rf for fits to filtered data; Ru for fits to unfiltered data) defined as




, where N is the number of data points.
 Re(  )  Im( ) 

 Re(  i calc ) 2  Im( icalc )2
N

1000*

i 1
N

i 1

d

iobs

2

iobs

2

Inclusion of a Co-C scattering path (0.5 C/Co), along with the parameters of this fit, led to a refined Co-C
distance of 2.53 Å (2 = 0.1 x 10-3 Å2), with a modest decrease in fit residual to Rf = 100.

e

Inclusion of a Co-C scattering path (0.5 C/Co), along with the parameters of this fit, led to a refined Co-C
distance of 2.52 Å (2 = 0.6 x 10-3 Å2), with a modest decrease in fit residual to Rf = 55.
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Figure 4-4. Fourier transforms (A) of k3-weighted EXAFS (B) for CoCo-BcII (solid

lines), and corresponding curve fits (open symbols) from Table 4-3.
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Table 4-3. Detailed EXAFS curve fitting results for CoCo-BcII.a
Fit

Model

Co-N/O

Co-S

S3-1

4.5 N/O

2.12 (5.1)

S3-2

4 N/O + 0.5 S

2.08 (1.8)

2.32 (1.7)

S3-5

4 N/O (2His) + 0.5 S d

2.08 (2.6)

2.33 (1.5)

Co-His b

Co-Co

Rf c

Ru c

119

309

92

288

172

221

125

202

2.95 (5.8), 3.19 (16)
4.13 (6.9), 4.32 (6.6)

4 N/O (2His) + 0.5 S
S3-6
a

2.09 (1.3)

+ Co-Co e

2.93 (1.8), 3.19 (14)

3.52

4.18 (14), 4.32 (12)

(8.4)

2.32 (1.4)

Distances (Å) and disorder parameters (in parentheses, 2 (10-3 Å2)) shown derive from integer or halfinteger coordination number fits to filtered EXAFS data [k = 1.5-12.4 Å-1; R = 0.7-2.3 Å (fits 1-2) or 0.24.2 Å (fits 3-4)].

b

Multiple scattering paths represent combined paths, as described previously (see Materials and Methods).

c

Goodness of fit (Rf for fits to filtered data; Ru for fits to unfiltered data) defined as




, where N is the number of data points.
 Re(  )  Im( ) 

 Re(  i calc ) 2  Im( icalc )2
N

1000*

i 1
N

i 1

d

iobs

2

iobs

2

Addition of a Co-C scattering path (0.5 C/Co) to the parameters of this fit led to a refined Co-C distance
of 2.47 Å (2 = 1.9 x 10-3 Å2), with a minimal decrease in fit residual to Rf = 168.

e

Addition of a Co-C scattering path (0.5 C/Co) to the parameters of this fit led to a refined Co-C distance
of 2.48 Å (2 = 1.0 x 10-3 Å2), with a minimal decrease in fit residual to Rf = 115.
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Figure 4-5. Fourier transforms (A) of k3-weighted EXAFS (B) for 0.5Zn-BcII (solid

lines), and corresponding curve fits (open symbols) from Table 4-4.
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Table 4-4. Detailed EXAFS curve fitting results for 0.5Zn-BcII.a
Fit

Model

Zn-N/O

Zn-S

S4-1

4.5 N/O

2.01 (6.6)

S4-2

4 N/O + 0.5 S

2.00 (4.9)

2.30 (5.8)

S4-3

4 N/O (2 His) + 0.5 S d

2.00 (4.5)

2.29 (6.3)

Zn-His b

Zn-Zn

Rf c

Ru c

113

207

71

181

34

63

26

53

2.93 (0.6), 3.18 (2.0)
4.11 (10), 4.43 (14)

4 N/O (2 His) + 0.5 S e
S4-4

2.00 (5.0)
+ Zn-Zn

a

2.95 (1.6), 3.21 (5.0)

3.41

4.12 (9.0), 4.41 (21)

(13)

2.30 (8.0)

Distances (Å) and disorder parameters (in parentheses, 2 (10-3 Å2)) shown derive from integer or halfinteger coordination number fits to filtered EXAFS data [k = 1.5-12.5 Å-1; R = 0.7-2.2 Å (fits 1-2) or 0.24.2 Å (fits 3-4)].

b

Multiple scattering paths represent combined paths, as described previously (see Materials and Methods).

c

Goodness of fit (Rf for fits to filtered data; Ru for fits to unfiltered data) defined as




, where N is the number of data points.
 Re(  )  Im( ) 

 Re(  i calc ) 2  Im( icalc )2
N

1000*

i 1
N

i 1

d

iobs

2

iobs

2

Inclusion of a Zn-C scattering path (0.5 C/Zn), along with the parameters of this fit, led to a refined Zn-C
distance of 2.49 Å (2 = 5.4 x 10-3 Å2), with a modest decrease in fit residual to Rf = 25.

e

Inclusion of a Zn-C scattering path (0.5 C/Zn), along with the parameters of this fit, led to a refined Zn-C
distance of 2.50 Å (2 = 5.1 x 10-3 Å2), with a modest decrease in fit residual to Rf = 18.
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Figure 4-6. Fourier transforms (A) of k3-weighted EXAFS (B) for 1Zn-BcII (solid lines),

and corresponding curve fits (open symbols) from Table 4-5.
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Table 4-5. Detailed EXAFS curve fitting results for 1Zn-BcII.a
Fit

Model

Zn-N/O

Zn-S

S5-1

4.5 N/O

2.00 (4.6)

S5-2

4 N/O + 0.5 S

2.00 (5.0)

2.29 (6.3)

S5-3

4 N/O (2 His) + 0.5 S d

2.00 (4.5)

2.29 (6.3)

Zn-His b

Zn-Zn

Rf c

Ru c

109

294

70

261

44

139

32

46

2.93 (0.6), 3.18 (2.0)
4.08 (12), 4.44 (14)

4 N/O (2 His) + 0.5 S
S5-4

2.03 (6.6)
+ Zn-Zn

a

2.93 (0.6), 3.18 (2.0)

3.41

4.08 (13), 4.44 (14)

(20)

2.30 (7.0)

Distances (Å) and disorder parameters (in parentheses, 2 (10-3 Å2)) shown derive from integer or halfinteger coordination number fits to filtered EXAFS data [k = 1.5-12.5 Å-1; R = 0.7-2.2 Å (fits 1-4) or 0.24.2 Å (fits 5-6)].

b

Multiple scattering paths represent combined paths, as described previously (see Materials and Methods).

c

Goodness of fit (Rf for fits to filtered data; Ru for fits to unfiltered data) defined as




, where N is the number of data points.
 Re(  )  Im( ) 

 Re(  i calc ) 2  Im( icalc )2
N

1000*

i 1
N

i 1

d

iobs

2

iobs

2

Inclusion of a Zn-C scattering path (0.5 C/Zn), along with the parameters of this fit, led to a refined Zn-C
distance of 2.50 Å (2 = 16 x 10-3 Å2), with a modest decrease in fit residual to Rf = 39.

e

Inclusion of a Zn-C scattering path (0.5 C/Zn), along with the parameters of this fit, led to a refined Zn-C
distance of 2.51 Å (2 = 11 x 10-3 Å2), with a modest decrease in fit residual to Rf = 39.
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Figure 4-7. Fourier transforms (A) of k3-weighted EXAFS (B) for ZnZn-BcII (solid

lines), and corresponding curve fits (open symbols) from Table 4-6.
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Table 4-6. Detailed EXAFS curve fitting results for ZnZn-BcII.a
Fit

Model

Zn-N/O

Zn-S

S6-1

4.5 N/O

2.02 (6.4)

S6-2

4 N/O + 0.5 S

2.01 (5.9)

2.29 (6.4)

S6-3

4 N/O (2His) + 0.5 S d

2.01 (5.8)

2.29 (6.0)

Zn-His b

Zn-Zn

Rf c

Ru c

96

214

57

206

19

89

10

71

2.93 (0.6), 3.17 (1.4)
4.09 (14), 4.43 (16)

4 N/O (2His) + 0.5 S e
S6-4
a

2.04 (6.3)

+ Zn-Zn e

2.90 (7.1), 3.18 (5.8)

3.42

4.08 (18), 4.43 (25)

(13)

2.27 (2.6)

Distances (Å) and disorder parameters (in parentheses, 2 (10-3 Å2)) shown derive from integer or halfinteger coordination number fits to filtered EXAFS data [k = 1.5-12.5 Å-1; R = 0.7-2.3 Å (Fits 1-2) or 0.24.0 Å (Fits 3-4)].

b

Multiple scattering paths represent combined paths, as described previously (see Materials and Methods).

c

Goodness of fit (Rf for fits to filtered data; Ru for fits to unfiltered data) defined as




, where N is the number of data points.
 Re(  )  Im( ) 

 Re(  i calc ) 2  Im( icalc )2
N

1000*

i 1
N

i 1

d

iobs

2

iobs

2

Addition of a Zn-C scattering path (0.5 C/Zn) to the parameters of this fit led to a refined Zn-C distance of
2.49 Å (2 = 10 x 10-3 Å2) and minimal improvement in fit residual to Rf = 16.

e

Addition of a Zn-C scattering path (0.5 C/Zn) to the parameters of this fit led to a refined Zn-C distance of
2.50 Å (2 = 1.3 x 10-3 Å2) and minor improvement in fit residual to Rf = 9.

132

Chapter V
Rapid Freeze Quench Studies of L1

This chapter includes work published in Breece, R.M.; Hu,; X. Bennett, B.; Crowder,
M.W.; Tierney D.L. Journal of the American Chemical Society, 2009, 131, 11642-11643.

Introduction

The mechanism of metallo--lactamses remains a target of great interest.
Understanding the mechanism could provide links between the three subclasses and
could lead to the eventual design of a universal inhibitor. Previous studies have looked at
the reaction kinetics of native and metal substituted L1. These studies have found that the
enzyme is active against a wide array of -lactam antibiotics. Against one cephalosporin,
nitrocefin, a reaction intermediate was discovered by stopped-flow UV-visible
spectroscopy. [1] The intermediate species displays a distinctive absorption at 665 nm
compared to 390 nm for the substrate and 485 nm for the product. The intermediate
structure is thought to be ring-opened with negative charge present on the formerly amide
nitrogen. Extended conjugation along the unique sidechain (Figure 5-1) is thought to
stabilize the intermediate. [1-4] Another report suggests that the negative charge is
stabilized by an interaction with the divalent active site metal [5], however the energy of
the absorption is independent of the metal present in the active site suggesting it is
primarily an intermediate based transition. [1, 6] A crystal structure of the ring-opened
product of the nitrocefin covalently linked to a class A penicillin binding protein [7]
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(Figure 5-2) suggests the nitrogen is involved in conjugation with the adjacent double
bond. The carbon-nitrogen-carbon bond angle in this structure is 129 degrees and is in
plane of the double bond. The dinitrostyrene sidechain appears to extend the conjugation.
Though in this structure, a rotation of the phenyl ring disrupts the planarity of the system.
This intermediate has been seen in the dizinc and dicobalt forms of L1, but its presence in
the monozinc form is diminished and it is not observed with monocobalt form. [8]
The metal binding behavior of the native and cobalt-substituted forms of the
enzyme has been well defined using EXAFS, [9] EPR, paramagnetic 1H NMR and UVvisible spectroscopy. [6] EXAFS showed the two equivalents of metal are bound at the
active site and the metals are bridged, with a zinc-zinc distance of 3.42 Å. [10] The
crystal structure of this enzyme shows the same site with an only slightly longer zinc-zinc
distance, 3.46 Å. Cobalt-substituted L1 differs from the native form. From EXAFS it
appears, the average coordination number of the active site increases by one half and the
average bond length increases by 0.07 Å. There is no evidence of a bridge between the
two metals and as such no cobalt-cobalt distance was observed. EXAFS of the product
complex of ZnZn L1 bound to the ring-opened nitrocefin indicates a rotation of the sixmembered ring, with the sulfur of the thioether binding to the zinc. This provides a sulfur
bound to the metal site which was detectable by EXAFS. [9]
Exploiting the sequential binding of L1, a ZnCo L1 [8] was produced to monitor
each metal site individually. The EXAFS of this species will be discussed later in this
chapter, but other kinetic and spectroscopic techniques have been previously reported.
ZnCo L1 was found to be as active as native L1. The UV-visible spectrum displays no
Co-S LMCT bands and the d-d bands reveal a series of broad peaks between 500-650 nm
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with a maximum extinction coefficient of 130 M-1 cm-1 consistent with a five coordinate
species. The paramagnetic 1H NMR displays one broad solvent exchangeable peak at
50ppm corresponding to two unresolved histidine residues based on integration. Stopped
flow studies with nitrocefin show the appearance of the reaction intermediate in a manner
similar to other dimetal L1’s. The EPR spectrum of CoZn L1 is similar to monocobalt L1
and is markedly different from CoCo L1. These pieces of information suggest that the
cobalt binds to the enzyme in the Zn2 (DHH) site, and that the zinc is bound at the Zn1
(3H) site.
In order to further elucidate the mechanism of B3 metallo--lactamase, L1,
hydrolysis of nitrocefin, a -lactam antibiotic, rapid freeze quench techniques were
utilized to structurally characterize the observed reaction intermediate. This technique
will be applied to the native dizinc L1, in addition to the mixed metal CoZn L1, in order
to look at the metal coordination at one time point within the reaction.

Experimental Procedures

L1 was prepared according to established procedures for initial studies, but a new
procedure was developed for producing CoZn L1. A single equivalent of cobalt was
incorporated biologically with a media very low in zinc and high in cobalt during periods
of overexpression. After spectroscopic verification of metal content, a direct addition of
zinc (II) brought the enzyme to the desired metal content. [11]
Rapid freeze quench samples were generated using a modified Update
Instruments (Madison, WI) rapid-freeze-quench system. Equal volumes of 1mM L1 and

135

5 mM nitrocefin, each containing 20% glycerol in 50 mM HEPES, pH 7.0, were rapidly
mixed (<1 ms), incubated at 2° C, and freeze-quenched in 2-methylbutane at -130° C.
[12] The total effective reaction time was 10ms; this was calibrated by comparing the
development of a low-spin Fe(III) EPR signal and the disappearance of a high-spin
Fe(III) EPR signal with the associated optical changes at 636 nm using stopped-flow
spectrophotometry, upon mixing myoglobin with an excess of sodium azide. The
syringes, mixer, and tubing were all maintained at 2° C using ice water. Immediately
prior to sample collection (< 1s), the nozzle and attached mixer were removed from the
bath and held 5 mm above the surface of 2-methylbutane contained in a collecting funnel
and maintained at -130° C by a surrounding bath of liquid nitrogen cooled 2methylbutane. Samples were packed into custom EXAFS cuvettes designed to interface
with this setup at -130° C and stored in liquid nitrogen. EXAFS data collection and
analysis were conducted according to methods previously reported. [13]

Results

The freeze-quenched di-zinc L1 reacted with nitrocefin shows moderate
differences from either the resting state or the product bound state. The best fit to the
freeze-quenched sample is an average primary coordination sphere of 4.5, which is
similar to the first shell coordination sphere of the resting enzyme. The average bond
length was fitted to 2.03 Å. There is no detectable presence of sulfur in the spectrum. The
addition of a half of a carbon at 2.45 Å (corresponding to a carboxylate ligand on one of
the two sites) improves the fit residual by 50%. The presence of a zinc shell at 3.72 Å
improves the fit residual by 70% (Table 5-1).
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The cobalt-zinc mixed-metal sample provides a baseline for comparison to the
freeze-quenched sample that will be described later. This sample contains one equivalent
of cobalt as over-expressed. The dinuclear site is formed by supplementing the monocobalt L1 by direct addition of zinc. The metal content was confirmed by ICP. The
EXAFS analysis shows a sequential binding of the metal with the cobalt being best fit by
a model corresponding to the Zn2 (DHH) site and the zinc being best fit by a model
corresponding to the Zn1 (3H) site. (Table 5-2) In vivo, the cobalt (II) is added to the Zn2
(DHH) site which is best fit to the data with 3 N/O (2.10 Å) and 2 N/O (1.94 Å) along
with 2 histidine ligands and a cobalt-zinc distance of 3.40 Å. (Table 5-2) Moving from a
single shell to multiple shells to characterize the intensity at a distance of 1.5 Å resulted
in a fit improvement of 75%. The difference in the distances between the two shells, 0.16
Å, is on the low edge of the resolutions of the data (0.14 Å). The addition of the cobaltzinc shell improves the fit residual by 40%. The direct addition of the zinc (II) completes
the active site binding to the Zn1 (3H) site. This site is well defined by a single shell of
four N/O at 2.00 Å with three histidine ligands and a zinc-cobalt distance of 3.42 Å. The
addition of the zinc-cobalt shell improves the fit by 32%. The correlation between the
metal-metal distance between the EXAFS of the two edges further supports the presence
of a water/hydroxide bridge between the two metals. A bridge between the two metals is
required in order to see the interaction.
A 10 ms freeze-quenched sample of the mixed-metal CoZn L1 with nitrocefin
display similar results to the resting mixed metal sample. The cobalt is bound to the Zn2
site and the zinc is bound to the Zn1 site. The coordination number at the cobalt remains
at five with no effective change in average bond length. (Table 5-3) The coordination
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number of the zinc moves from four to five, though the bond length does not show the
accompanying expansion that is expected. Without the increase in bond length, it is
unlikely that the higher coordination number is present. Upon addition of a metal-metal
shell to either of the fits, the distance refines to 3.75 Å. The fit residual improvement
however is only 4%. This improvement is too small to be considered. The lack of a
metal-metal interaction suggests the lack of a bridging species providing an order of the
two sites with respect to each other.

Discussion

The differences between the freeze-quenched samples suggest that we are looking
at a different state from either the resting or the product bound state. The state that was
captured displays similar coordination number to the two other stages of the reaction
mechanism we have studied. The maintenance of coordination number suggests that the
binding of substrate replaces ligands around the metal. The most likely ligand leaving the
metal would be the bridging or the terminal water. The coordination of the carboxylate to
the Zn1 (DHH) site would lead to the loss of either one of the bound residues, the
terminal water to the bulk solvent, or the bridging water/hydroxide to the Zn2. The loss of
the bridging water/hydroxide would lead to a more active nucleophile in the position to
attack the lactam carbonyl producing the ring-opened product. From the zinc-zinc
distance that was measured, this ring opening occurs within 10 ms, the minimum lag time
for our freeze quench apparatus. There is no sulfur present in the freezed-quench sample,
which would place this rotation at a timeframe after the 10 ms of the reaction. This
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provides the two extreme time points for the spectra acquired, but leaves a fair number of
stages of the reaction that our intermediate could represent.
One primary question is the state of the formerly amide based nitrogen.
Immediately after the ring opening reaction, the nitrogen would possess a formal negative
charge. Stabilization is possible due to the extended conjugation that extends out along
the dinitrostyrene side chain, found exclusively in nitrocefin. The negatively charged
nitrogen will ultimately become protonated as the product is released. The freezequenched sample may contain a protonated nitrogen, but the presence of the extended
conjugation and the intermediate observed under stopped-flow optical studies, suggest
that the negatively charged species may exist for a observable length of time. Another
possibility other than the protonation state of the nitrogen is that the negative charge is in
close proximity to the positively charged zinc ion. The opposing charges could
temporarily stabilize one another. Formation of a bond between the anionic nitrogen and
the zinc would decrease the reaction speed. In the freeze-quenched sample, the
coordination number of the Zn2 is five, which would suggest that the bond between the
nitrogen and the zinc has not formed. Otherwise, one of the exchangeable ligands would
have to be released.
A comparable structure is the crystal structure of L1 complexed with hydrolyzed
moxalactam. [14] This structure shows a larger average coordination sphere from 4.5 to
5.5 and a solvent derived bridge molecule. It also displays a bond between the former
amide nitrogen to Zn2. The formation of the Zn-N bond will be strong due to the excess
electron density on the nitrogen after the cleavage of the bond. The strength of this bond
will have likely impede release of the product and contribute to the stability of the
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complex. The change in coordination number between the L1-moxalactam crystal
structure and this freeze-quenched species may be explained by the lack of a solvent
molecule bridging the two metals, though the zinc-zinc distance is only modestly
elongated (3.68 Å vs 3.72 Å). The higher coordination number of the moxalactam
complex will tend towards higher average ligand bond lengths, which will allow for a
more relaxed Zn-O-Zn bond angle. The freeze-quenched nitrocefin sample has a lower
average bond distance and a longer zinc-zinc distance, which would push the bond angle
more towards linear.
The CoZn L1 sample provides a unique opportunity for us it allows us to probe
the individual metal sites in the di-metal enzyme. Previously, the study of subclass B2
would provide insight into the Zn2 site and monosubstituted enzymes of subclasses B1
and B3 could provide insight into the Zn1 site. Due to the limitations of the spectroscopic
techniques employed, the dizinc or dicobalt forms are observable as an average of the
two sites (EXAFS) or as a sum of two individual spectra that can be difficult to resolve.
The mixed metal sample allows for the probing of each site independent of the other.
Combined with the versatility of x-ray spectroscopy, one sample may be analyzed for
both elements, removing the variation that can be present among samples biologically
prepared. This situation is ideal for the freeze-quenched experiments, in that the
coordination number of both metals in the reaction mechanism can be probed separately
giving us a closer look at the mechanism that is present. Kinetics studies show that the
CoZn L1 retains 67% of the native activity, which could indicate that the enzyme retains
the same mechanism. [8]
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The mixed-metal sample has been studied previously using UV-visible,
paramagnetic nuclear magnetic resonance, and electron paramagnetic resonance
spectroscopies. These studies suggest the cobalt binds to the Zn2 (DHH) site of L1. The
UV-visible spectrum displays multiple unresolved peaks between 500-650 nm with a net
extinction coefficient of 130 M-1cm-1. These features are commonly ascribed to 5coordinate cobalt (II). The spectra the 1 Co L1 and the CoZn L1 display are identical, but
are different from CoCo L1. This suggests that the cobalt occupies one unique location
instead of occupying an average of the two sites. The NMR spectra display one broad
peak that was solvent exchangeable at 50 ppm. The integration of this peak showed that it
was equivalent to two protons. These protons would correspond to the solvent
exchangeable protons of the two histidine ligands bound to the metal. This spectrum was
similar to the precursor 1 Co L1 sample before the addition of zinc, which suggests that
the addition of zinc minimally disrupts the cobalt binding. The EPR spectroscopy was
found to contain two species attributed to the equilibrium between Co(II)-H2O and
Co(II)-OH. These findings are in agreement with what we have observed. The cobalt
locates in the Zn2 (DHH) site and is bound to two water/hydroxide ligands and the zinc
binds in the Zn1 (3H) site with a single water/hydroxide.
The freeze-quenched CoZn L1 sample provides multiple points of comparison.
First, the freeze-quenched sample may be compared with the CoZn L1 sample. This will
provide two stages along the reaction pathway. Direct comparison between the zinc and
the cobalt spectra between the two samples will allow us to look at both of the sites at ten
milliseconds into the reaction. At this time frame it appears that the ring opening reaction
has occurred. The lack of a definitive metal-metal distance adds some ambiguity to the
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placement within the reaction scheme. The metal-metal distance refines to 3.75 Å at both
the zinc and cobalt edges, though the improvement in the fit residual (4%) is too low to
be considered. Apart from the lack of a visible metal-metal distance, the cobalt-edge
remains similar to the resting enzyme in both bond length and coordination number. This
can be explained by replacing the bridging hydroxide with the substrate carboxylate.
The zinc-edge spectrum shows some differences from the resting state spectrum.
Although the average bond length is unchanged, the refined coordination number is
larger, which suggests that the site has acquired an additional ligand or that the site has
become more ordered. Within the reaction scheme, there are two stages where the Zn1
(3H) site should be five-coordinate. As the substrate binds, the lactam carbonyl will bind
to the Zn1 (3H) site, while the metal remains bound to a hydroxide/water and after the
nucleophilic attack on the lactam, the newly formed carboxylic acid may temporarily
assume a bidentate binding mode. These cases should move to a four-coordinate zinc as
the reaction progresses.
Second CoZn L1 may be compared to the ZnZn L1 sample to compare both
reactions at the same time frame. With the overall reaction taking 50% longer (25.6 ms
vs. 38.4 ms as calculated from kcat), the 10 ms time frame may show different stages of
the reaction. The stopped flow of comparison of the dizinc L1 and ZnCo L1 shows that
there is a significant population of the intermediate present in both samples. Alternatively
if both are at the rate-limiting step of the reaction, the freeze quenched CoZn L1 sample
may provide insight into the activity occurring at each of the two metals within the
reaction. What has been observed is that the average of the two sites in the freeze-
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quenched CoZn L1 sample, averaging a coordination number of 4.5 with 2.5 histidines is
similar to the freeze-quenched ZnZn L1 sample.
This study provides a look at a single state of the reaction mechanism that is
primarily characterized by similar coordination numbers and an increase of metal-metal
distance. The implications of this metal-metal distance is that the ring opening reaction is
rapid in the reaction scheme and that the slower steps of this reaction are the protonation
events that facilitate product release. Based on the proposed reaction mechanism, two
protons are required for product release. The first is the cycloamine. After the cleavage of
the lactam bond, this nitrogen would possess a formal negative charge, which is
stabilized by resonance in nitrocefin. In other species that do not display the intermediate
in stopped-flow UV-visible spectroscopy, this species remains for an even a shorter time.
The other ligand that would facilitate product release by protonation is the ring-bound
carboxylate. The release of this group is necessary for the rotation that allows for the
thioether to be bound to the zinc. The proton source remains in question. The possible
sources are active site residues, the terminal water, and local water molecules. With the
proximity to the metal, the loss of a proton from either of the water ligands could aid in
the later formation of a hydroxide bridge between the metal sites.
It may be possible to understand the enzymatic mechanism as a function of metalmetal distance. The resting state of the enzyme maintains the hydroxide/water bridge and
a metal-metal distance of 3.4 Å. At 10 ms of reaction time, this distance has been
extended to 3.72 Å. With the product bound, the distance is intermediate to the two at
3.62 Å. One means of enzymatic activity is the substrate binds to both metals, through the
carbonyl to one and through the carboxylic acid to the other, then the bridge between the
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metals breaks and enzymatic motions moves the metals apart. This provides a tension on
the four-membered lactam ring, which is then hydrolyzed by the metal-bound hydroxide.
In the following steps, the system relaxes and the metals move closer together.
The 10 ms examined here is the shortest time that the commercial freeze-quench
apparatus can attain, therefore to capture earlier stages in the reaction a custom apparatus
must be constructed. Additionally later time frames may be helpful in elucidating the
stages after the ring opening. The combination of the longer and shorter time frames will
provide a more complete scheme by which the reaction proceeds. Subtle protonation
events may beyond the ability of EXAFS to probe, but the rotation of the six-membered
ring could be monitored by looking for the appearance of the metal-sulfur bond. The loss
and reformation of the hydroxide bridge between the metals should also be a possible
target for EXAFS studies.

Summary
These studies have delved into the mechanism of the metallo--lactamase L1.
Rapid freeze quenching of L1 samples reacted with nitrocefin was collected at 10 ms into
the reaction. The EXAFS data show that there is an increase in the zinc-zinc distance
upon ring opening that is greater than in the L1 nitrocefin product complex. Additionally,
the production of mixed metal samples has greatly increased the capabilities of EXAFS
analysis of these systems. Monitoring each metal site individually in the system removes
a limitation with x-ray absorption techniques, which studies an average of the metal
population. Mixed metal L1 combined the rapid freeze quenching allowed for the metal
environment of both sites of the enzyme to be separately studied.
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Figure 5-1: Structure of Nitrocefin
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Figure 5-2: Crystal Structure of Ring-Opened Nitrocefin.
(Rendered with RasMol from 2UWX)
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Figure 5-3: L1 bound to ring-opened Moxalactam
(Rendered with RasMol from 2aio)
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Table 5-1. Detailed EXAFS curve fitting results for freeze-quenched ZnZn-L1. a

Fit

Model

Zn-N/O

Zn-S

Zn-His b

Zn-Zn

Rf c

Ru

112

330

31

70

21

65

Rf c

Ru

124

216

82

192

26

156

ZnZn-L1
1

2.03 (5.6)
4.5 N/O
2.08 (3.8)

2

2.5 N + 2 O
1.94 (1.3)
2N+2O

2.18 (24)

+ 0.5 S

1.97 (1.3)

2.24 (3.1)

3

Fit

Model

Zn-N/O

Zn-C

4.5 N/O
4

Zn-Zn

2.90 (4.3), 3.15 (10)
2.03 (10)

(2.5 His)

4.13 (20), 4.36 (15)

4.5 N/O + 0.5 C
5

2.89 (4.2), 3.12 (13)
2.03 (10)

2.45 (0.3)

(2.5 His)

4.11 (16), 4.36 (17)

4.5 N/O + 0.5 C
6

2.03 (10)

2.86 (6.1), 3.15 (10)

3.72

4.12 (8.7), 4.35 (14)

(6.6)

2.45 (0.2)

(2.5 His) + Zn-Zn
a

Zn-His b

Distances (Å) and disorder parameters (in parentheses, 2 (10-3 Å2)) shown derive from integer
or half-integer coordination number fits to filtered EXAFS data [Zn-edge: k = 1.5-13.7 Å-1; R
= 0.7-2.2 Å (Fits 1-3), R = 0.2-4.0 Å (Fits 4-6) ]

b

Multiple scattering paths represent combined paths, as described previously (see Materials and
Methods)




Goodness of fit (Rf for fits to filtered data) defined as 1000* Re(  )  Im( )  , where N is the

 Re(  i calc ) 2  Im( icalc )2
N

c

i 1
N

i 1

number of data points

151

iobs

2

iobs

2

Figure 5-4. Fourier transforms (A) of k3-weighted EXAFS (B) for ZnZn-L1, freeze-quenched after 10
ms reaction with nitrocefin (solid lines), and corresponding curve fits (open symbols) from Table 5-1.

152

Table 5-2. Detailed EXAFS curve fitting results for CoZn-L1. a

Fit

Model

M-His b

M-N/O

M-M

Rf c

Ru

13

206

31

70

21

65

275

514

74

322

90

183

54

169

CoZn-L1 (Zn edge)
2.00 (4.5)
4 N/O
2.90 (4.7), 3.14 (2.8)
4 N/O (3 His)

2.00 (4.3)
4.10 (18), 4.41 (20)

4 N/O (3 His)

2.90 (5.6), 3.13 (3.7)
2.01 (6.1)

+ Co-Zn

3.42 (13)
4.22 (26), 4.41 (16)

CoZn-L1 (Co edge)
2.16 (9.9)
4 N/O
3N

2.10 (2.2)

2O

1.94 (1.2)

3N

2.10 (3.0)

2.81 (3.8), 3.13 (2.1)

2O (2 His)

1.94 (2.6)

3.95 (5.1), 4.52 (7.8)

2.10 (2.3)

2.84 (8.2), 3.14 (6.6)

1.94 (1.5)

3.79 (7.0), 4.53 (10)

3N
2O (2 His)

3.40 (6.9)

+Co-Zn
a

Distances (Å) and disorder parameters (in parentheses, 2 (10-3 Å2)) shown derive from integer or
half-integer coordination number fits to filtered EXAFS data [Zn-edge: k = 1.5-14 Å-1; R = 0.1-4.0 Å;
Co-edge: k = 1.5-12.5 Å-1; R = 0.1-4.1 Å]

b

Multiple scattering paths represent combined paths, as described previously (see Materials and
Methods)




, where N is the
 Re(  )  Im( ) 

 Re(  i calc ) 2  Im( icalc )2
N

c

Goodness of fit (Rf for fits to filtered data) defined as 1000*

i 1
N

i 1

number of data points
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iobs

2

iobs

2

Figure 5-5. Fourier transforms (A) of k3-weighted EXAFS (B) for the zinc edge of CoZn-L1 (solid
lines), and corresponding curve fits (open symbols) from Table 5-2.
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Figure 5-6. Fourier transforms (A) of k3-weighted EXAFS (B) for the cobalt edge of CoZn-L1 (solid
lines), and corresponding curve fits (open symbols) from Table 5-2.
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Table 5-3. Detailed EXAFS curve fitting results for freeze-quenched CoZn-L1. a

Fit

Model

M-His b

M-N/O

M-M

Rf c

Ru

11

293

77

195

74

194

86

500

36

408

58

231

56

220

CoZn-L1 (Zn edge)
2.02 (3.3)
5 N/O
2.91 (5.8), 3.17 (4.2)
5 N/O (3 His)

2.02 (4.3)
4.17 (27), 4.43 (19)

5 N/O (3 His)

2.91 (5.7), 3.16 (3.7)
2.02 (5.5)

+ Co-Zn

3.75 (18)
4.07 (33), 4.41 (19)

CoZn-L1 (Co edge)
2.07 (8.6)
4 N/O
2.11 (0.2)
3N + 2O
1.95 (1.8)
2.08 (0.8)

2.83 (5.0), 3.11 (0.4)

1.94 (1.0)

3.95 (2.1), 4.51 (4.4)

2.08 (0.8)

2.82 (5.8), 3.11 (0.5)

1.94 (1.1)

4.13 (0.9), 4.52 (3.4)

3N + 2O (2 His)
3N + 2O (2 His)

3.77 (3.7)
+ Co-Zn
a

Distances (Å) and disorder parameters (in parentheses, 2 (10-3 Å2)) shown derive from
integer or half-integer coordination number fits to filtered EXAFS data [Zn-edge: k =
1.5-14 Å-1; R = 0.1-4.0 Å;

b

Co edge: k = 1.5-12.5 Å-1; R = 0.1-4.1 Å]

Multiple scattering paths represent combined paths, as described previously (see
Materials and Methods)




Goodness of fit (Rf for fits to filtered data) defined as 1000* Re(  )  Im( )  , where

 Re(  i calc ) 2  Im( icalc )2
N

c

i 1
N

i 1

N is the number of data points
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Figure 5-7. Fourier transforms (A) of k3-weighted EXAFS (B) for the zinc edge of CoZnL1, freeze-quenched after 10 ms reaction with nitrocefin (solid lines), and corresponding
curve fits (open symbols) from Table 5-3.
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Figure 5-8. Fourier transforms (A) of k3-weighted EXAFS (B) for the cobalt edge
of CoZn-L1, freeze-quenched after 10 ms reaction with nitrocefin (solid lines),
and corresponding curve fits (open symbols) from Table 5-3.
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Chapter VI
Summary and Future Work

This work builds upon the foundation of previous work using x-ray absorption
spectroscopy in the analysis of metallo--lactamases. This research has used x-ray
absorption spectroscopy to explore the metal binding behavior within the B1 subclass and
probes the mechanism of the B3 subclass. Most importantly, this work presents a series
of tools and techniques that will aid in further explorations of the structure and function
of this superfamily of enzymes.

Metal Binding Behavior of Metallo--Lactamases

To date, three members of subclass B1 have been characterized by x-ray
absorption spectroscopy. In each case, they provide different metal binding behavior. The
first, CcrA, has been seen to follow sequential binding. BcII binds metals to both sites
when exposed to divalent metal ions. Bla2 binds zinc differently than cobalt, with zinc
binding like CcrA and cobalt binding like BcII. This variation within one subclass,
suggests that the previous strategy of taking one member of each subclass as an example
will provide an incomplete picture of that subclass. To address this issue, studies are
being expanded to other members of the subclasses. Future studies should include Imp1
and MDN, B1 metallo--lactamases that are more commonly found in clinical settings.
The differential binding in Bla2 provides another difference in the behavior of
cobalt and zinc in enzymes. Cobalt is often used as a spectroscopic probe of zinc metallo-
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proteins, but previous research has suggested that the resting state of cobalt-substituted
enzyme contains additional solvent molecules compared to the zinc-containing enzyme.
This is a case that the differences between the two metals alone are enough to affect the
binding behavior. This suggests that in the zinc case the binding affinity between the Zn1
and Zn2 sites are different enough that there is preferential binding to the Zn1 site,
however for cobalt, the binding affinity to the two sites are more similar, allowing for the
two sites to become occupied simultaneously. This is the first case of the metal binding
being different between zinc and cobalt. With minimal differences in the two sites,
mutagensis should be used to convert the active sites and mimic the other site's metal
binding behavior.
The sequential nature of the metal to these enzymes allowed for the production of
the mixed metal forms, which allows for the study of each site individually in the
bimetallic enzyme. These studies have shown that the formation of ZnCo L1 is possible
and that it forms a bridged species similar to that of the native dizinc L1. Future studies
should use this mixed metal approach to explore any of the other metallo--lactamases
that display sequential binding, including CcrA and potentially Bla2 starting from a 1 Zn
Bla2 foundation. Any of these potential forms may then be used to explore the
differences between that and the L1.

Mechanism of Metallo-b-Lactamases

Using rapid freeze quenched samples, a reaction intermediate was characterized
in the reaction of L1 with nitrocefin. This intermediate expands the information provided
previously by the crystal structure of L1 and moxalactam. The freeze-quenched sample
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shows a ring-opened intermediate at 10 ms. This ring opening displays a metal-metal
distance longer than either the resting enzyme or the product-bound enzyme. Further
study should expand the type of enzyme and the type of -lactam antibiotics. Other
antibiotics do not display the optically observable intermediate, but could provide insight
into the mechanism with respect to more commonly employed antibiotics in the clinical
setting. Looking at other subclasses of enzymes could be used to look for commonalities
and differences between the different reaction mechanisms. Additionally, looking at L1
with a single equivalent of metal could provide a nice comparison with the B2 subclass of
enzyme, looking at how this versatile active site reacts at both the metal sites. Finally,
probing additional time points would alloy for the study of the full duration of the
reaction and look at the enzyme returning to the resting state.
The combination of the mixed metal form and the rapid freeze-quenching
techniques allows us to look at the reaction in even more detail. Study of the coordination
number and bond length of the individual sites will allow for the probing of different
stages within the reaction mechanism. Currently, two time points have been collected, the
resting form and the 10 ms time frame. The mixed metal form with product bound is one
of the next data sets to be collected. Additional time points, after 10 ms will allow for the
study of those alterations that lead to the product bound form as well as the relaxation
towards the resting state of the enzyme. The construction of an apparatus for looking at
shorter time frames is of greater interest, in order to look at species before the ring
opening, particularly the substrate binding step.
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